{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T06:30:40Z","timestamp":1772692240190,"version":"3.50.1"},"publisher-location":"Cham","reference-count":256,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032085290","type":"print"},{"value":"9783032085306","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-08530-6_6","type":"book-chapter","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T01:56:56Z","timestamp":1767319016000},"page":"299-353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Epigenetic Angle in the Precision Medicine Era for Blood Disorder Advancements"],"prefix":"10.1007","author":[{"given":"Nadia M.","family":"Hamdy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed I.","family":"Abulsoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nehal I.","family":"Rizk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohada M.","family":"AL-Noshokaty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Bakr Zaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed S.","family":"Sultan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed S.","family":"Doghish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"issue":"1","key":"6_CR1","doi-asserted-by":"publisher","first-page":"18790","DOI":"10.1038\/s41598-023-45214-z","volume":"13","author":"MA Abd-Elmawla","year":"2023","unstructured":"Abd-Elmawla, M. A., Y. A. Elsabagh and N. M. Aborehab (2023). \"Association of XIST\/miRNA155\/Gab2\/TAK1 cascade with the pathogenesis of anti-phospholipid syndrome and its effect on cell adhesion molecules and inflammatory mediators.\" Scientific Reports 13(1): 18790.","journal-title":"Scientific Reports"},{"issue":"6","key":"6_CR2","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3390\/cancers12061445","volume":"12","author":"A Abramowicz","year":"2020","unstructured":"Abramowicz, A. and M. D. Story (2020). \"The long and short of it: the emerging roles of non-coding RNA in small extracellular vesicles.\" Cancers 12(6): 1445.","journal-title":"Cancers"},{"key":"6_CR3","doi-asserted-by":"crossref","unstructured":"Abubakar, M., M. Hajjaj, Z. e. Z. Naqvi, H. Shanawaz, A. Naeem, S. S. N. Padakanti, C. Bellitieri, R. Ramar, F. Gandhi and A. Saleem (2024). \"Non-coding RNA-mediated gene regulation in cardiovascular disorders: current insights and future directions.\" Journal of Cardiovascular Translational Research 17(4): 739\u2013767.","DOI":"10.1007\/s12265-023-10469-4"},{"key":"6_CR4","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.prostaglandins.2018.09.005","volume":"139","author":"R Adili","year":"2018","unstructured":"Adili, R., M. Hawley and M. Holinstat (2018). \"Regulation of platelet function and thrombosis by omega-3 and omega-6 polyunsaturated fatty acids.\" Prostaglandins Other Lipid Mediat 139: 10\u201318.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"4","key":"6_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.5045\/br.2018.53.4.320","volume":"53","author":"A Ahmadi","year":"2018","unstructured":"Ahmadi, A., S. Kaviani, M. Yaghmaie, H. Pashaiefar, M. Ahmadvand, M. Jalili, K. Alimoghaddam, M. Eslamijouybari and A. Ghavamzadeh (2018). \"Altered expression of MALAT1 lncRNA in chronic lymphocytic leukemia patients, correlation with cytogenetic findings.\" Blood research 53(4): 320.","journal-title":"Blood research"},{"key":"6_CR6","doi-asserted-by":"crossref","unstructured":"Al-Hawary, S. I. S., R. O. Saleh, S. G. Taher, S. M. Ahmed, A. Hjazi, A. Yumashev, P. Ghildiyal, M. T. Qasim, A. Alawadi and A. Ihsan (2024). \"Tumor-derived lncRNAs; Behind-the-scenes mediators that modulate the immune system and play a role in cancer pathogenesis.\" Pathology-Research and Practice: 155123.","DOI":"10.1016\/j.prp.2024.155123"},{"key":"6_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.hermed.2019.100316","volume":"20","author":"A AlAskar","year":"2020","unstructured":"AlAskar, A., N. A. Shaheen, A. H. Khan, N. AlGhasham, M. A. Mendoza, D. B. Matar, G. Gmati, M. AlJeraisy and A. AlSuhaibani (2020). \"Effect of daily ginger consumption on platelet aggregation.\" Journal of Herbal Medicine 20: 100316.","journal-title":"Journal of Herbal Medicine"},{"key":"6_CR8","doi-asserted-by":"publisher","first-page":"1007347","DOI":"10.3389\/fmolb.2022.1007347","volume":"9","author":"MA Ali","year":"2022","unstructured":"Ali, M. A., S. K. Hussein, A. A. Khalifa, A. M. El Amin Ali, M. S. Farhan, A. A. Ibrahim Amin and E. A. Mohamed (2022). \"The Ifng antisense RNA 1 (IFNG-AS1) and growth arrest-specific transcript 5 (GAS5) are novel diagnostic and prognostic markers involved in childhood ITP.\" Frontiers in Molecular Biosciences 9: 1007347.","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"4","key":"6_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.55705\/cmbr.2022.360799.1062","volume":"2","author":"HK Alsaedy","year":"2022","unstructured":"Alsaedy, H. K., A. R. Mirzaei and R. A. H. Alhashimi (2022). \"Investigating the structure and function of Long Non-Coding RNA (LncRNA) and its role in cancer.\" Cellular, Molecular Biomedical Reports 2(4): 245\u2013253.","journal-title":"Cellular, Molecular Biomedical Reports"},{"key":"6_CR10","doi-asserted-by":"crossref","unstructured":"Alvarez-Dominguez, J. R., W. Hu, B. Yuan, J. Shi, S. S. Park, A. A. Gromatzky, A. v. Oudenaarden and H. F. Lodish (2014). \"Global discovery of erythroid long noncoding RNAs reveals novel regulators of red cell maturation.\" Blood, The Journal of the American Society of Hematology 123(4): 570\u2013581.","DOI":"10.1182\/blood-2013-10-530683"},{"key":"6_CR11","doi-asserted-by":"crossref","unstructured":"Alzeer, J. (2023). \"Integrating medicine with lifestyle for personalized and holistic healthcare.\" Journal of Public Health and Emergency 7.","DOI":"10.21037\/jphe-23-71"},{"issue":"1","key":"6_CR12","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1182\/hematology.2020000092","volume":"2020","author":"JE Amengual","year":"2020","unstructured":"Amengual, J. E. (2020). \"Can we use epigenetics to prime chemoresistant lymphomas?\" Hematology Am Soc Hematol Educ Program 2020(1): 85\u201394.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"9","key":"6_CR13","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1038\/s41375-018-0067-3","volume":"32","author":"N Amodio","year":"2018","unstructured":"Amodio, N., M. A. Stamato, G. Juli, E. Morelli, M. Fulciniti, M. Manzoni, E. Taiana, L. Agnelli, M. E. G. Cantafio and E. Romeo (2018). \"Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity.\" Leukemia 32(9): 1948\u20131957.","journal-title":"Leukemia"},{"issue":"1","key":"6_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1186\/s12935-022-02815-4","volume":"22","author":"MM Anwar","year":"2022","unstructured":"Anwar, M. M., C. Albanese, N. M. Hamdy and A. S. Sultan (2022). \"Rise of the natural red pigment \u2018prodigiosin\u2019 as an immunomodulator in cancer.\" Cancer Cell International 22(1): 419.","journal-title":"Cancer Cell International"},{"key":"6_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.579940","volume":"10","author":"K Arman","year":"2020","unstructured":"Arman, K. and T. M\u00f6r\u00f6y (2020). \"Crosstalk between MYC and lncRNAs in hematological malignancies.\" Frontiers in Oncology 10: 579940.","journal-title":"Frontiers in Oncology"},{"key":"6_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106427","volume":"133","author":"H Atta","year":"2023","unstructured":"Atta, H., N. Alzahaby, N. M. Hamdy, S. H. Emam, A. Sonousi and L. Ziko (2023). \"New trends in synthetic drugs and natural products targeting 20S proteasomes in cancers.\" Bioorganic Chemistry 133: 106427.","journal-title":"Bioorganic Chemistry"},{"issue":"9","key":"6_CR17","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/iub.2310","volume":"72","author":"SE Ayoub","year":"2020","unstructured":"Ayoub, S. E., E. M. Hefzy, R. G. Abd El-Hmid, N. A. Ahmed, A. A. Khalefa, D. Y. Ali and M. A. Ali (2020). \"Analysis of the expression profile of long non-coding RNAs MALAT1 and THRIL in children with immune thrombocytopenia.\" IUBMB life 72(9): 1941\u20131950.","journal-title":"IUBMB life"},{"key":"6_CR18","volume-title":"American ginseng modulation of immune function and phytochemical analysis","author":"CG Azike","year":"2014","unstructured":"Azike, C. G. (2014). American ginseng modulation of immune function and phytochemical analysis, The University of Western Ontario (Canada)."},{"issue":"3","key":"6_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4236\/jbm.2019.73007","volume":"7","author":"D Babarykin","year":"2019","unstructured":"Babarykin, D., G. Smirnova, I. Pundinsh, S. Vasiljeva, G. Krumina and V. Agejchenko (2019). \"Red beet (Beta vulgaris) impact on human health.\" Journal of biosciences and medicines 7(3): 61\u201379.","journal-title":"Journal of biosciences and medicines"},{"key":"6_CR20","doi-asserted-by":"crossref","unstructured":"Bai, J., A. Guo, Z. Hong and W. Kuai (2012). \"Upregulation of microRNA-100 predicts poor prognosis in patients with pediatric acute myeloid leukemia.\" OncoTargets and therapy: 213-219.","DOI":"10.2147\/OTT.S36017"},{"issue":"1","key":"6_CR21","doi-asserted-by":"publisher","first-page":"dvae006","DOI":"10.1093\/eep\/dvae006","volume":"10","author":"E Bartova","year":"2024","unstructured":"Bartova, E. (2024). \"Epigenetic and gene therapy in human and veterinary medicine.\" Environ Epigenet 10(1): dvae006.","journal-title":"Environ Epigenet"},{"issue":"19","key":"6_CR22","doi-asserted-by":"publisher","first-page":"7140","DOI":"10.3390\/ijms21197140","volume":"21","author":"M Bauer","year":"2020","unstructured":"Bauer, M., C. Vaxevanis, N. Heimer, H. K. Al-Ali, N. Jaekel, M. Bachmann, C. Wickenhauser and B. Seliger (2020). \"Expression, regulation and function of microRNA as important players in the transition of MDS to secondary AML and their cross talk to RNA-binding proteins.\" International Journal of Molecular Sciences 21(19): 7140.","journal-title":"International Journal of Molecular Sciences"},{"key":"6_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1146\/annurev-pharmtox-010716-105106","volume":"58","author":"RL Bennett","year":"2018","unstructured":"Bennett, R. L. and J. D. Licht (2018). \"Targeting Epigenetics in Cancer.\" Annu Rev Pharmacol Toxicol 58: 187\u2013207.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"6_CR24","doi-asserted-by":"publisher","first-page":"204062071881669","DOI":"10.1177\/2040620718816698","volume":"10","author":"JP Bewersdorf","year":"2019","unstructured":"Bewersdorf, J. P., R. Shallis, M. Stahl and A. M. Zeidan (2019). \"Epigenetic therapy combinations in acute myeloid leukemia: what are the options?\" Ther Adv Hematol 10: 2040620718816698.","journal-title":"Ther Adv Hematol"},{"key":"6_CR25","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s11011-021-00739-y","volume":"36","author":"GK Bhatti","year":"2021","unstructured":"Bhatti, G. K., N. Khullar, I. S. Sidhu, U. S. Navik, A. P. Reddy, P. H. Reddy and J. S. Bhatti (2021). \"Emerging role of non-coding RNA in health and disease.\" Metabolic brain disease 36: 1119\u20131134.","journal-title":"Metabolic brain disease"},{"key":"6_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejphar.2018.08.021","volume":"837","author":"S Biswas","year":"2018","unstructured":"Biswas, S. and C. M. Rao (2018). \"Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy.\" European Journal of Pharmacology 837: 8\u201324.","journal-title":"European Journal of Pharmacology"},{"issue":"22","key":"6_CR27","doi-asserted-by":"publisher","first-page":"8855","DOI":"10.3390\/ijms21228855","volume":"21","author":"EA Braga","year":"2020","unstructured":"Braga, E. A., M. V. Fridman, A. A. Moscovtsev, E. A. Filippova, A. A. Dmitriev and N. E. Kushlinskii (2020). \"LncRNAs in ovarian cancer progression, metastasis, and main pathways: ceRNA and alternative mechanisms.\" International journal of molecular sciences 21(22): 8855.","journal-title":"International journal of molecular sciences"},{"issue":"2","key":"6_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2174\/1574884711666160603012237","volume":"11","author":"G Bulaj","year":"2016","unstructured":"Bulaj, G., M. M. Ahern, A. Kuhn, Z. S. Judkins, R. C. Bowen and Y. Chen (2016). \"Incorporating Natural Products, Pharmaceutical Drugs, Self-Care and Digital\/Mobile Health Technologies into Molecular-Behavioral Combination Therapies for Chronic Diseases.\" Curr Clin Pharmacol 11(2): 128\u2013145.","journal-title":"Curr Clin Pharmacol"},{"issue":"5\u20136","key":"6_CR29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1159\/000519237","volume":"15","author":"M Burgos","year":"2021","unstructured":"Burgos, M., A. Hurtado, R. Jim\u00e9nez and F. J. Barrionuevo (2021). \"Non-coding RNAs: lncRNAs, miRNAs, and piRNAs in sexual development.\" Sexual Development 15(5\u20136): 335\u2013350.","journal-title":"Sexual Development"},{"issue":"D1","key":"6_CR30","doi-asserted-by":"publisher","first-page":"D279","DOI":"10.1093\/nar\/gkab1033","volume":"50","author":"L Cai","year":"2022","unstructured":"Cai, L., J. Xuan, Q. Lin, J. Wang, S. Liu, F. Xie, L. Zheng, B. Li, L. Qu and J. Yang (2022). \"Pol3Base: a resource for decoding the interactome, expression, evolution, epitranscriptome and disease variations of Pol III-transcribed ncRNAs.\" Nucleic acids research 50(D1): D279-D286.","journal-title":"Nucleic acids research"},{"issue":"8","key":"6_CR31","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.3390\/cancers13081976","volume":"13","author":"A Carrasco-Leon","year":"2021","unstructured":"Carrasco-Leon, A., A. Amundarain, N. Gomez-Echarte, F. Prosper and X. Agirre (2021). \"The role of lncRNAs in the pathobiology and clinical behavior of multiple myeloma.\" Cancers 13(8): 1976.","journal-title":"Cancers"},{"issue":"1","key":"6_CR32","first-page":"1","volume":"6","author":"L Ceclu","year":"2020","unstructured":"Ceclu, L. and O.-V. Nistor (2020). \"Red beetroot: Composition and health effects\u2014A review.\" J. Nutr. Med. Diet Care 6(1): 1-9.","journal-title":"J. Nutr. Med. Diet Care"},{"issue":"11","key":"6_CR33","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1073\/pnas.1200677109","volume":"109","author":"AA Chaudhuri","year":"2012","unstructured":"Chaudhuri, A. A., A. Y.-L. So, A. Mehta, A. Minisandram, N. Sinha, V. D. Jonsson, D. S. Rao, R. M. O'Connell and D. Baltimore (2012). \"Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A.\" Proceedings of the National Academy of Sciences 109(11): 4233\u20134238.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"6_CR34","first-page":"2203","volume":"18","author":"C Chen","year":"2019","unstructured":"Chen, C., P. Wang, W. Mo, Y. Zhang, W. Zhou, T. Deng, M. Zhou, X. Chen, S. Wang and C. Wang (2019). \"lncRNA-CCDC26, as a novel biomarker, predicts prognosis in acute myeloid leukemia.\" Oncology letters 18(3): 2203\u20132211.","journal-title":"Oncology letters"},{"issue":"6","key":"6_CR35","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1080\/15476286.2020.1726637","volume":"17","author":"L Chen","year":"2020","unstructured":"Chen, L., X. Fan, J. Zhu, X. Chen, Y. Liu and H. Zhou (2020). \"LncRNA MAGI2-AS3 inhibits the self-renewal of leukaemic stem cells by promoting TET2-dependent DNA demethylation of the LRIG1 promoter in acute myeloid leukaemia.\" RNA biology 17(6): 784\u2013793.","journal-title":"RNA biology"},{"issue":"28","key":"6_CR36","doi-asserted-by":"publisher","first-page":"11511","DOI":"10.1073\/pnas.1310144110","volume":"110","author":"P Chen","year":"2013","unstructured":"Chen, P., C. Price, Z. Li, Y. Li, D. Cao, A. Wiley, C. He, S. Gurbuxani, R. B. Kunjamma and H. Huang (2013). \"miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia\u2013rearranged leukemia.\" Proceedings of the National Academy of Sciences 110(28): 11511\u201311516.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"2","key":"6_CR37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/cdd.2016.111","volume":"24","author":"Z-H Chen","year":"2017","unstructured":"Chen, Z.-H., W.-T. Wang, W. Huang, K. Fang, Y.-M. Sun, S.-R. Liu, X.-Q. Luo and Y.-Q. Chen (2017a). \"The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway.\" Cell Death & Differentiation 24(2): 212\u2013224.","journal-title":"Cell Death & Differentiation"},{"issue":"2","key":"6_CR38","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/cdd.2016.111","volume":"24","author":"Z-H Chen","year":"2017","unstructured":"Chen, Z.-H., W.-T. Wang, W. Huang, K. Fang, Y.-M. Sun, S.-R. Liu, X.-Q. Luo and Y.-Q. Chen (2017b). \"The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway.\" Cell Death and Differentiation 24(2): 212\u2013224.","journal-title":"Cell Death and Differentiation"},{"issue":"5","key":"6_CR39","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/leu.2014.333","volume":"29","author":"M Chuang","year":"2015","unstructured":"Chuang, M., Y. Chiu, W. Chou, H. Hou, E. Chuang and H. Tien (2015). \"A 3-microRNA scoring system for prognostication in de novo acute myeloid leukemia patients.\" Leukemia 29(5): 1051\u20131059.","journal-title":"Leukemia"},{"issue":"1","key":"6_CR40","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3390\/biomedicines12010201","volume":"12","author":"P Chunarkar-Patil","year":"2024","unstructured":"Chunarkar-Patil, P., M. Kaleem, R. Mishra, S. Ray, A. Ahmad, D. Verma, S. Bhayye, R. Dubey, H. N. Singh and S. Kumar (2024). \"Anticancer Drug Discovery Based on Natural Products: From Computational Approaches to Clinical Studies.\" Biomedicines 12(1): 201.","journal-title":"Biomedicines"},{"issue":"9","key":"6_CR41","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMp1500523","volume":"372","author":"FS Collins","year":"2015","unstructured":"Collins, F. S. and H. Varmus (2015). \"A new initiative on precision medicine.\" N Engl J Med 372(9): 793\u2013795.","journal-title":"N Engl J Med"},{"issue":"10","key":"6_CR42","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.3390\/pharmaceutics13101681","volume":"13","author":"P Connerty","year":"2021","unstructured":"Connerty, P., E. Moles, C. E. de Bock, N. Jayatilleke, J. L. Smith, S. Meshinchi, C. Mayoh, M. Kavallaris and R. B. Lock (2021). \"Development of siRNA-loaded lipid nanoparticles targeting long non-coding RNA LINC01257 as a novel and safe therapeutic approach for t (8; 21) pediatric acute myeloid leukemia.\" Pharmaceutics 13(10): 1681.","journal-title":"Pharmaceutics"},{"key":"6_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.859710","volume":"9","author":"D Coriu","year":"2022","unstructured":"Coriu, D., N. Dirzu, A. A. Zimta, B. C. Hambley, X. Liu, L. Nemes, G. Ghiaur, J. Mahlangu and C. Tomuleasa (2022). \"Editorial: Modern Approaches to Hemophilia Management: Gene Therapy and Beyond.\" Front Med (Lausanne) 9: 859710.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"6_CR44","first-page":"133","volume":"70","author":"MB Covington","year":"2004","unstructured":"Covington, M. B. (2004). \"Omega-3 fatty acids.\" American family physician 70(1): 133\u2013140.","journal-title":"American family physician"},{"key":"6_CR45","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-1-4939-8751-1_5","volume":"1856","author":"N Cruz-Rodriguez","year":"2018","unstructured":"Cruz-Rodriguez, N., A. L. Combita and J. Zabaleta (2018). \"Epigenetics in Hematological Malignancies.\" Methods Mol Biol 1856: 87\u2013101.","journal-title":"Methods Mol Biol"},{"issue":"4","key":"6_CR46","first-page":"546","volume":"124","author":"B Cui","year":"2014","unstructured":"Cui, B., L. Chen, S. Zhang, M. Mraz, J.-F. Fecteau, J. Yu, E. M. Ghia, L. Zhang, L. Bao and L. Z. Rassenti (2014). \"MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia.\" Blood, The Journal of the American Society of Hematology 124(4): 546\u2013554.","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"6_CR47","doi-asserted-by":"crossref","unstructured":"Cui, Y.-L., B. Wang, H.-M. Gao, Y.-H. Xing, J. Li, H.-J. Li, Z. Lin and Y.-Q. Wang (2016). \"Interleukin-18 and miR-130a in severe sepsis patients with thrombocytopenia.\" Patient preference and adherence: 313\u2013319.","DOI":"10.2147\/PPA.S95588"},{"issue":"1","key":"6_CR48","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41392-024-02039-0","volume":"9","author":"W Dai","year":"2024","unstructured":"Dai, W., X. Qiao, Y. Fang, R. Guo, P. Bai, S. Liu, T. Li, Y. Jiang, S. Wei, Z. Na, X. Xiao and D. Li (2024). \"Epigenetics-targeted drugs: current paradigms and future challenges.\" Signal Transduct Target Ther 9(1): 332.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"6_CR49","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1158\/0008-5472.CAN-13-1733","volume":"74","author":"DC De Leeuw","year":"2014","unstructured":"De Leeuw, D. C., F. Denkers, M. C. Olthof, A. P. Rutten, W. Pouwels, G. Jan Schuurhuis, G. J. Ossenkoppele and L. Smit (2014). \"Attenuation of microRNA-126 expression that drives CD34+ 38\u2212 stem\/progenitor cells in acute myeloid leukemia leads to tumor eradication.\" Cancer research 74(7): 2094\u20132105.","journal-title":"Cancer research"},{"issue":"4","key":"6_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1704","volume":"13","author":"M Deogharia","year":"2022","unstructured":"Deogharia, M. and P. Gurha (2022). \"The \u201cguiding\u201d principles of noncoding RNA function.\" Wiley Interdisciplinary Reviews: RNA 13(4): e1704.","journal-title":"Wiley Interdisciplinary Reviews: RNA"},{"issue":"5","key":"6_CR51","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41576-020-00309-5","volume":"22","author":"B DeVeale","year":"2021","unstructured":"DeVeale, B., J. Swindlehurst-Chan and R. Blelloch (2021). \"The roles of microRNAs in mouse development.\" Nature Reviews Genetics 22(5): 307\u2013323.","journal-title":"Nature Reviews Genetics"},{"issue":"13","key":"6_CR52","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s40265-020-01389-7","volume":"80","author":"S Dhillon","year":"2020","unstructured":"Dhillon, S. (2020). \"Decitabine\/Cedazuridine: First Approval.\" Drugs 80(13): 1373\u20131378.","journal-title":"Drugs"},{"key":"6_CR53","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ijbiomac.2021.12.141","volume":"197","author":"AS Doghish","year":"2022","unstructured":"Doghish, A. S., A. Ismail, H. A. El-Mahdy, M. A. Elkady, M. A. Elrebehy and A.-A. M. Sallam (2022). \"A review of the biological role of miRNAs in prostate cancer suppression and progression.\" International journal of biological macromolecules 197: 141\u2013156.","journal-title":"International journal of biological macromolecules"},{"issue":"1","key":"6_CR54","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1182\/asheducation-2017.1.45","volume":"2017","author":"H Dombret","year":"2017","unstructured":"Dombret, H. and R. Itzykson (2017). \"How and when to decide between epigenetic therapy and chemotherapy in patients with AML.\" Hematology Am Soc Hematol Educ Program 2017(1): 45\u201353.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"6_CR55","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3389\/fphar.2019.00045","volume":"10","author":"H Dong","year":"2019","unstructured":"Dong, H., S. Jiang, Y. Fu, Y. Luo, R. Gui and J. Liu (2019). \"Upregulation of lncRNA NR_046683 serves as a prognostic biomarker and potential drug target for multiple myeloma.\" Frontiers in Pharmacology 10: 45.","journal-title":"Frontiers in Pharmacology"},{"issue":"11","key":"6_CR56","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1038\/leu.2015.139","volume":"29","author":"AM Dorrance","year":"2015","unstructured":"Dorrance, A. M., P. Neviani, G. J. Ferenchak, X. Huang, D. Nicolet, K. S. Maharry, H. G. Ozer, P. Hoellarbauer, J. Khalife and E. B. Hill (2015). \"Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia.\" Leukemia 29(11): 2143\u20132153.","journal-title":"Leukemia"},{"key":"6_CR57","doi-asserted-by":"crossref","unstructured":"Drissen, R., M. von Lindern, A. Kolbus, S. Driegen, P. Steinlein, H. Beug, F. Grosveld, S. J. M. Philipsen and c. biology (2005). \"The erythroid phenotype of EKLF-null mice: defects in hemoglobin metabolism and membrane stability.\" Molecular and cellular biology 25(12): 5205\u20135214.","DOI":"10.1128\/MCB.25.12.5205-5214.2005"},{"key":"6_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2020.102417","volume":"82","author":"M-Y Duan","year":"2020","unstructured":"Duan, M.-Y., M. Li, H. Tian, G. Tang, Y.-C. Yang and N.-C. Peng (2020). \"Down-regulation of lncRNA NEAT1 regulated by miR-194-5p\/DNMT3A facilitates acute myeloid leukemia.\" Blood Cells, Molecules, and Diseases 82: 102417.","journal-title":"Blood Cells, Molecules, and Diseases"},{"key":"6_CR59","doi-asserted-by":"publisher","unstructured":"Dzobo, K. The Role of Natural Products as Sources of Therapeutic Agents for Innovative Drug Discovery, Comprehensive Pharmacology. 2022:408\u201322. doi: https:\/\/doi.org\/10.1016\/B978-0-12-820472-6.00041-4. Epub 2022 Jun 9.","DOI":"10.1016\/B978-0-12-820472-6.00041-4"},{"key":"6_CR60","doi-asserted-by":"crossref","unstructured":"Eckschlager, T., J. Plch, M. Stiborova and J. Hrabeta (2017). \"Histone Deacetylase Inhibitors as Anticancer Drugs.\" Int J Mol Sci 18(7).","DOI":"10.3390\/ijms18071414"},{"issue":"8","key":"6_CR61","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1007\/s00432-014-1670-y","volume":"140","author":"HO El Mesallamy","year":"2014","unstructured":"El Mesallamy, H. O., W. M. Rashed, N. M. Hamdy and N. Hamdy (2014). \"High-dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next?\" Journal of Cancer Research and Clinical Oncology 140(8): 1359\u20131365.","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"5","key":"6_CR62","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/ncrna9050058","volume":"9","author":"S Eldash","year":"2023","unstructured":"Eldash, S., E. F. Sanad, D. Nada and N. M. Hamdy (2023). \"The Intergenic Type LncRNA (LINC RNA) Faces in Cancer with In Silico Scope and a Directed Lens to LINC00511: A Step toward ncRNA Precision.\" Non-Coding RNA 9(5): 58.","journal-title":"Non-Coding RNA"},{"issue":"9","key":"6_CR63","first-page":"65","volume":"67","author":"M Eltarouty","year":"2024","unstructured":"Eltarouty, M., M. A. Eldesoky, F. B. Rashidi, S. Matbouly and N. El-Khazargy (2024). \"The Expression Profile of MicroRNA LET-7a-5p in Children with Idiopathic Thrombocytopenic Purpura.\" Egyptian Journal of Chemistry 67(9): 65\u201375.","journal-title":"Egyptian Journal of Chemistry"},{"issue":"5","key":"6_CR64","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/leu.2013.357","volume":"28","author":"S Emmrich","year":"2014","unstructured":"Emmrich, S., J. Katsman-Kuipers, K. Henke, M. Khatib, R. Jammal, F. Engeland, F. Dasci, C. Zwaan, M. Den Boer and L. Verboon (2014). \"miR-9 is a tumor suppressor in pediatric AML with t (8; 21).\" Leukemia 28(5): 1022\u20131032.","journal-title":"Leukemia"},{"issue":"2","key":"6_CR65","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jtcme.2023.10.004","volume":"14","author":"M Entezari","year":"2024","unstructured":"Entezari, M., A. Tayari, M. D. A. Paskeh, S. K. Kheirabad, S. Naeemi, A. Taheriazam, H. Dehghani, S. Salimimoghadam, M. Hashemi, S. Mirzaei and S. Samarghandian (2024). \"Curcumin in treatment of hematological cancers: Promises and challenges.\" J Tradit Complement Med 14(2): 121\u2013134.","journal-title":"J Tradit Complement Med"},{"issue":"3","key":"6_CR66","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3233\/CH-1996-16306","volume":"16","author":"D Erdinyler","year":"1996","unstructured":"Erdinyler, D., Y. Karakoy, S. Toplan, S. Onen, A. Sukyasyan, T. Beger and \u00c7. Demiro\u011flu (1996). \"The effect of Ginkgo biloba glycoside on the blood viscosity and erythrocyte deformability.\" Clinical Hemorheology and Microcirculation 16(3): 271\u2013276.","journal-title":"Clinical Hemorheology and Microcirculation"},{"issue":"6","key":"6_CR67","doi-asserted-by":"publisher","first-page":"5147","DOI":"10.3390\/cimb46060309","volume":"46","author":"N Evangelidis","year":"2024","unstructured":"Evangelidis, N., N. Kotsiou, P. Evangelidis, V. I. Alevizopoulos, I. Dermitzakis, S. Chissan, S. Vakalopoulou and E. Gavriilaki (2024). \"Genetics and Epigenetics in Acquired Hemophilia A: From Bench to Bedside.\" Curr Issues Mol Biol 46(6): 5147\u20135160.","journal-title":"Curr Issues Mol Biol"},{"key":"6_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40164-016-0033-6","volume":"5","author":"AJ Favreau","year":"2015","unstructured":"Favreau, A. J., R. E. McGlauflin, C. W. Duarte and P. Sathyanarayana (2015). \"miR-199b, a novel tumor suppressor miRNA in acute myeloid leukemia with prognostic implications.\" Experimental hematology & oncology 5: 1\u201311.","journal-title":"Experimental hematology & oncology"},{"issue":"D1","key":"6_CR69","doi-asserted-by":"publisher","first-page":"D204","DOI":"10.1093\/nar\/gkab1101","volume":"50","author":"B Fromm","year":"2022","unstructured":"Fromm, B., E. H\u00f8ye, D. Domanska, X. Zhong, E. Aparicio-Puerta, V. Ovchinnikov, S. U. Umu, P. J. Chabot, W. Kang and M. Aslanzadeh (2022). \"MirGeneDB 2.1: toward a complete sampling of all major animal phyla.\" Nucleic acids research 50(D1): D204-D210.","journal-title":"Nucleic acids research"},{"issue":"10","key":"6_CR70","doi-asserted-by":"publisher","first-page":"5838","DOI":"10.3390\/ijms23105838","volume":"23","author":"Z Ga\u00e1l","year":"2022","unstructured":"Ga\u00e1l, Z. (2022). \"Implication of microRNAs in carcinogenesis with emphasis on hematological malignancies and clinical translation.\" International Journal of Molecular Sciences 23(10): 5838.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"6_CR71","doi-asserted-by":"publisher","first-page":"10924","DOI":"10.1038\/s41598-022-15162-1","volume":"12","author":"P Galka-Marciniak","year":"2022","unstructured":"Galka-Marciniak, P., Z. Kandu\u0142a, A. Tire, W. Wegorek, K. Gwozdz-Bak, L. Handschuh, M. Giefing, K. Lewandowski and P. Kozlowski (2022). \"Mutations in the miR-142 gene are not common in myeloproliferative neoplasms.\" Scientific Reports 12(1): 10924.","journal-title":"Scientific Reports"},{"key":"6_CR72","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3389\/fcell.2019.00207","volume":"7","author":"V Gambacorta","year":"2019","unstructured":"Gambacorta, V., D. Gnani, L. Vago and R. Di Micco (2019). \"Epigenetic Therapies for Acute Myeloid Leukemia and Their Immune-Related Effects.\" Front Cell Dev Biol 7: 207.","journal-title":"Front Cell Dev Biol"},{"issue":"31","key":"6_CR73","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1038\/onc.2011.62","volume":"30","author":"X Gao","year":"2011","unstructured":"Gao, X., J. Lin, Y. Li, L. Gao, X. Wang, W. Wang, H. Kang, G. Yan, L. Wang and L. Yu (2011). \"MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.\" Oncogene 30(31): 3416\u20133428.","journal-title":"Oncogene"},{"issue":"7\u20138","key":"6_CR74","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/10408363.2017.1410520","volume":"54","author":"JL Garc\u00eda-Gim\u00e9nez","year":"2017","unstructured":"Garc\u00eda-Gim\u00e9nez, J. L., M. Seco-Cervera, T. O. Tollefsbol, C. Rom\u00e1-Mateo, L. Peir\u00f3-Chova, P. Lapunzina and F. V. Pallard\u00f3 (2017). \"Epigenetic biomarkers: Current strategies and future challenges for their use in the clinical laboratory.\" Crit Rev Clin Lab Sci 54(7\u20138): 529\u2013550.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"6","key":"6_CR75","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1016\/S2352-3026(19)30029-8","volume":"6","author":"G Garcia-Manero","year":"2019","unstructured":"Garcia-Manero, G., G. Roboz, K. Walsh, H. Kantarjian, E. Ritchie, P. Kropf, C. O'Connell, R. Tibes, S. Lunin, T. Rosenblat, K. Yee, W. Stock, E. Griffiths, J. Mace, N. Podoltsev, J. Berdeja, E. Jabbour, J. J. Issa, Y. Hao, H. N. Keer, M. Azab and M. R. Savona (2019). \"Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1\/2 trial.\" Lancet Haematol 6(6): e317-e327.","journal-title":"Lancet Haematol"},{"issue":"26","key":"6_CR76","first-page":"5331","volume":"114","author":"R Garzon","year":"2009","unstructured":"Garzon, R., C. E. Heaphy, V. Havelange, M. Fabbri, S. Volinia, T. Tsao, N. Zanesi, S. M. Kornblau, G. Marcucci and G. A. Calin (2009). \"MicroRNA 29b functions in acute myeloid leukemia.\" Blood, The Journal of the American Society of Hematology 114(26): 5331\u20135341.","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"1","key":"6_CR77","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ncrna.2020.12.002","volume":"6","author":"S Ghafouri-Fard","year":"2021","unstructured":"Ghafouri-Fard, S., V. Niazi and M. Taheri (2021). \"Role of miRNAs and lncRNAs in hematopoietic stem cell differentiation.\" Non-coding RNA research 6(1): 8\u201314.","journal-title":"Non-coding RNA research"},{"issue":"5","key":"6_CR78","first-page":"1532","volume":"100","author":"DG Gilliland","year":"2002","unstructured":"Gilliland, D. G. and J. D. Griffin (2002). \"The roles of FLT3 in hematopoiesis and leukemia.\" Blood, The Journal of the American Society of Hematology 100(5): 1532\u20131542.","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"1","key":"6_CR79","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/cdd.2013.133","volume":"21","author":"J Gong","year":"2014","unstructured":"Gong, J., J. Yu, H. Lin, X. Zhang, X. Yin, Z. Xiao, F. Wang, X. Wang, R. Su and C. Shen (2014). \"The role, mechanism and potentially therapeutic application of microRNA-29 family in acute myeloid leukemia.\" Cell Death & Differentiation 21(1): 100\u2013112.","journal-title":"Cell Death & Differentiation"},{"key":"6_CR80","doi-asserted-by":"crossref","unstructured":"Goodell, M. A. and L. A. J. B. Godley, The Journal of the American Society of Hematology (2013). \"Perspectives and future directions for epigenetics in hematology.\" 121(26): 5131\u20135137.","DOI":"10.1182\/blood-2013-04-427724"},{"issue":"3","key":"6_CR81","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/10408398009527278","volume":"12","author":"V Govindarajan","year":"1980","unstructured":"Govindarajan, V. and W. H. Stahl (1980). \"Turmeric\u2014chemistry, technology, and quality.\" Critical Reviews in Food Science & Nutrition 12(3): 199\u2013301.","journal-title":"Critical Reviews in Food Science & Nutrition"},{"issue":"12","key":"6_CR82","doi-asserted-by":"publisher","first-page":"2000027","DOI":"10.1002\/bies.202000027","volume":"42","author":"J Graf","year":"2020","unstructured":"Graf, J. and M. Kretz (2020). \"From structure to function: Route to understanding lncRNA mechanism.\" BioEssays 42(12): 2000027.","journal-title":"BioEssays"},{"issue":"1","key":"6_CR83","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1186\/s12967-024-05554-4","volume":"22","author":"K Grillone","year":"2024","unstructured":"Grillone, K., G. Carid\u00e0, F. Luciano, A. Cordua, M. T. Di Martino, P. Tagliaferri and P. Tassone (2024). \"A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer.\" Journal of Translational Medicine 22(1): 731.","journal-title":"Journal of Translational Medicine"},{"key":"6_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2022.103849","volume":"180","author":"X Guan","year":"2022","unstructured":"Guan, X., Y. Sun and C. Zhang (2022). \"LncRNAs in blood cells: Roles in cell development and potential pathogenesis in hematological malignancies.\" Critical Reviews in Oncology\/Hematology 180: 103849.","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"6_CR85","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00432-019-02896-1","volume":"145","author":"N Gupta","year":"2019","unstructured":"Gupta, N., R. Kumar, T. Seth, B. Garg, H. C. Sati and A. Sharma (2019). \"Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma.\" Journal of Cancer Research and Clinical Oncology 145: 1601\u20131611.","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"4","key":"6_CR86","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1056\/NEJMp1006304","volume":"363","author":"MA Hamburg","year":"2010","unstructured":"Hamburg, M. A. and F. S. Collins (2010). \"The path to personalized medicine.\" N Engl J Med 363(4): 301\u2013304.","journal-title":"N Engl J Med"},{"issue":"11","key":"6_CR87","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1080\/03007995.2024.2416985","volume":"40","author":"NM Hamdy","year":"2024","unstructured":"Hamdy, N. M., E. B. Basalious, M. G. El-Sisi, M. Nasr, A. M. Kabel, E. S. Nossier and A. H. Abadi (2024a). \"Advancements in current one-size-fits-all therapies compared to future treatment innovations for better improved chemotherapeutic outcomes: a step-toward personalized medicine.\" Current Medical Research and Opinion 40(11): 1943\u20131961.","journal-title":"Current Medical Research and Opinion"},{"key":"6_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.138773","volume":"289","author":"NM Hamdy","year":"2025","unstructured":"Hamdy, N. M., M. B. Zaki, N. M. Abdelmaksoud, R. A. Ismail, M. A. Abd-Elmawla, N. I. Rizk, D. Fathi and A. I. Abulsoud (2025). \"Insights into the genetic and epigenetic mechanisms governing X-chromosome-linked-miRNAs expression in cancer; a step-toward ncRNA precision.\" International Journal of Biological Macromolecules 289: 138773.","journal-title":"International Journal of Biological Macromolecules"},{"key":"6_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122946","volume":"354","author":"NM Hamdy","year":"2024","unstructured":"Hamdy, N. M., M. B. Zaki, N. I. Rizk, N. M. Abdelmaksoud, M. A. Abd-Elmawla, R. A. Ismail and A. I. Abulsoud (2024b). \"Unraveling the ncRNA landscape that governs colorectal cancer: A roadmap to personalized therapeutics.\" Life Sciences 354: 122946.","journal-title":"Life Sciences"},{"issue":"4","key":"6_CR90","doi-asserted-by":"publisher","first-page":"635","DOI":"10.52547\/rbmb.11.4.635","volume":"11","author":"SM Hamdy","year":"2023","unstructured":"Hamdy, S. M., M. S. Ali, R. G. Abd El-Hmid, N. K. Abdelghaffar and O. O. Abdelaleem (2023). \"Role of long non coding RNAs, NEAT1 and Lnc-DC expression in pediatric immune thrombocytopenic purpura.\" Reports of Biochemistry & Molecular Biology 11(4): 635.","journal-title":"Reports of Biochemistry & Molecular Biology"},{"issue":"8","key":"6_CR91","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1002\/ijc.29199","volume":"136","author":"M Hao","year":"2015","unstructured":"Hao, M., M. Zang, E. Wendlandt, Y. Xu, G. An, D. Gong, F. Li, F. Qi, Y. Zhang and Y. Yang (2015). \"Low serum mi R-19a expression as a novel poor prognostic indicator in multiple myeloma.\" International journal of cancer 136(8): 1835\u20131844.","journal-title":"International journal of cancer"},{"issue":"3","key":"6_CR92","doi-asserted-by":"publisher","first-page":"e395","DOI":"10.1097\/MPH.0000000000002580","volume":"45","author":"H Hodeib","year":"2023","unstructured":"Hodeib, H., D. El Amrousy, E. Elaskary, N. Hablas, A. Youssef and D. Abdelhai (2023). \"lncRNA GAS5 and RUNX1 Genes in Children With Primary Immune Thrombocytopenia.\" Journal of Pediatric Hematology\/Oncology 45(3): e395-e400.","journal-title":"Journal of Pediatric Hematology\/Oncology"},{"issue":"1","key":"6_CR93","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1038\/s41598-021-82509-5","volume":"11","author":"M Hofmans","year":"2021","unstructured":"Hofmans, M., T. Lammens, B. Depreter, Y. Wu, M. Erlacher, A. Caye, H. Cav\u00e9, C. Flotho, V. de Haas and C. M. Niemeyer (2021). \"Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia.\" Scientific reports 11(1): 2801.","journal-title":"Scientific reports"},{"key":"6_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-5822-y","volume":"19","author":"H-H Huang","year":"2019","unstructured":"Huang, H.-H., F.-Y. Chen, W.-C. Chou, H.-A. Hou, B.-S. Ko, C.-T. Lin, J.-L. Tang, C.-C. Li, M. Yao and W. Tsay (2019). \"Long non-coding RNA HOXB-AS3 promotes myeloid cell proliferation and its higher expression is an adverse prognostic marker in patients with acute myeloid leukemia and myelodysplastic syndrome.\" BMC cancer 19: 1\u201314.","journal-title":"BMC cancer"},{"issue":"1","key":"6_CR95","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/cells13010084","volume":"13","author":"W Huang","year":"2023","unstructured":"Huang, W., D. Paul, G. A. Calin and R. Bayraktar (2023). \"miR-142: A Master Regulator in Hematological Malignancies and Therapeutic Opportunities.\" Cells 13(1): 84.","journal-title":"Cells"},{"issue":"13","key":"6_CR96","doi-asserted-by":"publisher","first-page":"6573","DOI":"10.7150\/thno.55664","volume":"11","author":"MR Iaquinta","year":"2021","unstructured":"Iaquinta, M. R., C. Lanzillotti, C. Mazziotta, I. Bononi, F. Frontini, E. Mazzoni, L. Oton-Gonzalez, J. C. Rotondo, E. Torreggiani and M. Tognon (2021). \"The role of microRNAs in the osteogenic and chondrogenic differentiation of mesenchymal stem cells and bone pathologies.\" Theranostics 11(13): 6573.","journal-title":"Theranostics"},{"issue":"3","key":"6_CR97","doi-asserted-by":"publisher","first-page":"280","DOI":"10.15616\/BSL.2018.24.3.280","volume":"24","author":"M Irfan","year":"2018","unstructured":"Irfan, M., M. Kim, H.-W. Kwon, M. H. Rhee and H.-K. Kim (2018). \"Antiplatelet effects of garlic and chitosan: a comparative study between fermented and non-fermented preparations.\" Biomedical Science Letters 24(3): 280\u2013284.","journal-title":"Biomedical Science Letters"},{"key":"6_CR98","unstructured":"Jabeena, S., M. A. Hanifa, M. M. Khanb and R. W. K. Qadric (2014). \"Natural products sources and their active compounds on disease prevention: A.\" health 6(7)."},{"issue":"3","key":"6_CR99","first-page":"653","volume":"26","author":"Z-W Jia","year":"2018","unstructured":"Jia, Z.-W., Y. Li, G.-R. Cui, H.-B. Zhao, P.-Y. Li and J.-M. Luo (2018). \"Expression and clinical significance of LncRNA KCNQ1OT1 in patients with acute myeloid leukemia.\" Zhongguo Shi Yan Xue Ye Xue Za Zhi 26(3): 653\u2013657.","journal-title":"Zhongguo Shi Yan Xue Ye Xue Za Zhi"},{"issue":"4","key":"6_CR100","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/ijlh.14041","volume":"45","author":"N Jiang","year":"2023","unstructured":"Jiang, N., Y. Wang, Q. Feng, S. Wang, S. Leng, X. Zhang, Q. Liu, J. Peng and X. Li (2023). \"Plasma long noncoding RNAs lncDC and THRIL as potential diagnostic markers of adult primary immune thrombocytopenia.\" International Journal of Laboratory Hematology 45(4): 481\u2013488.","journal-title":"International Journal of Laboratory Hematology"},{"issue":"1","key":"6_CR101","doi-asserted-by":"publisher","first-page":"11452","DOI":"10.1038\/ncomms11452","volume":"7","author":"X Jiang","year":"2016","unstructured":"Jiang, X., C. Hu, S. Arnovitz, J. Bugno, M. Yu, Z. Zuo, P. Chen, H. Huang, B. Ulrich and S. Gurbuxani (2016). \"miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia.\" Nature communications 7(1): 11452.","journal-title":"Nature communications"},{"issue":"3","key":"6_CR102","first-page":"4001","volume":"16","author":"Y Jiang","year":"2018","unstructured":"Jiang, Y., Y. Luan, H. Chang and G. Chen (2018). \"The diagnostic and prognostic value of plasma microRNA-125b-5p in patients with multiple myeloma.\" Oncology letters 16(3): 4001\u20134007.","journal-title":"Oncology letters"},{"issue":"1","key":"6_CR103","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/cts.12884","volume":"14","author":"KB Johnson","year":"2021","unstructured":"Johnson, K. B., W. Q. Wei, D. Weeraratne, M. E. Frisse, K. Misulis, K. Rhee, J. Zhao and J. L. Snowdon (2021). \"Precision Medicine, AI, and the Future of Personalized Health Care.\" Clin Transl Sci 14(1): 86\u201393.","journal-title":"Clin Transl Sci"},{"issue":"4","key":"6_CR104","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.cell.2007.01.029","volume":"128","author":"PA Jones","year":"2007","unstructured":"Jones, P. A. and S. B. Baylin (2007). \"The epigenomics of cancer.\" Cell 128(4): 683\u2013692.","journal-title":"Cell"},{"key":"6_CR105","doi-asserted-by":"crossref","unstructured":"Kalinkova, L., A. Sevcikova, V. Stevurkova, I. Fridrichova and S. Ciernikova (2022). \"Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool.\" Int J Mol Sci 24(1).","DOI":"10.3390\/ijms24010633"},{"issue":"10","key":"6_CR106","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1080\/10245332.2016.1173341","volume":"21","author":"AM Kamal","year":"2016","unstructured":"Kamal, A. M., N. M. Hamdy, H. M. Hegab and H. O. El-Mesallamy (2016). \"Expression of thioredoxin-1 (TXN) and its relation with oxidative DNA damage and treatment outcome in adult AML and ALL: A comparative study.\" Hematology 21(10): 567\u2013575.","journal-title":"Hematology"},{"issue":"4","key":"6_CR107","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3390\/cancers13040593","volume":"13","author":"K Katsaraki","year":"2021","unstructured":"Katsaraki, K., P. Karousi, P. I. Artemaki, A. Scorilas, V. Pappa, C. K. Kontos and S. G. Papageorgiou (2021). \"MicroRNAs: Tiny regulators of gene expression with pivotal roles in normal B-Cell development and B-Cell chronic lymphocytic leukemia.\" Cancers 13(4): 593.","journal-title":"Cancers"},{"issue":"3","key":"6_CR108","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nm0313-249","volume":"19","author":"A Katsnelson","year":"2013","unstructured":"Katsnelson, A. (2013). \"Momentum grows to make 'personalized' medicine more 'precise'.\" Nat Med 19(3): 249.","journal-title":"Nat Med"},{"issue":"10","key":"6_CR109","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/nbt.1678","volume":"28","author":"TK Kelly","year":"2010","unstructured":"Kelly, T. K., D. D. De Carvalho and P. A. Jones (2010). \"Epigenetic modifications as therapeutic targets.\" Nat Biotechnol 28(10): 1069\u20131078.","journal-title":"Nat Biotechnol"},{"key":"6_CR110","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.addr.2015.05.012","volume":"87","author":"O Khorkova","year":"2015","unstructured":"Khorkova, O., J. Hsiao and C. Wahlestedt (2015). \"Basic biology and therapeutic implications of lncRNA.\" Advanced drug delivery reviews 87: 15\u201324.","journal-title":"Advanced drug delivery reviews"},{"issue":"8","key":"6_CR111","first-page":"1539","volume":"68","author":"D Kiefer","year":"2003","unstructured":"Kiefer, D. and T. Pantuso (2003). \"Panax ginseng.\" American family physician 68(8): 1539\u20131542.","journal-title":"American family physician"},{"key":"6_CR112","doi-asserted-by":"crossref","unstructured":"Kim, M. Y., B. Yan, S. Huang and Y. Qiu (2020). \"Regulating the Regulators: The Role of Histone Deacetylase 1 (HDAC1) in Erythropoiesis.\" Int J Mol Sci 21(22).","DOI":"10.3390\/ijms21228460"},{"issue":"23","key":"6_CR113","doi-asserted-by":"publisher","first-page":"4804","DOI":"10.1182\/blood-2009-04-217794","volume":"114","author":"EA Kimbrel","year":"2009","unstructured":"Kimbrel, E. A., M. E. Lemieux, X. Xia, T. N. Davis, V. I. Rebel and A. L. Kung (2009). \"Systematic in vivo structure-function analysis of p300 in hematopoiesis.\" Blood 114(23): 4804\u20134812.","journal-title":"Blood"},{"issue":"2","key":"6_CR114","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nrd3625","volume":"11","author":"R Kole","year":"2012","unstructured":"Kole, R., A. R. Krainer and S. Altman (2012). \"RNA therapeutics: beyond RNA interference and antisense oligonucleotides.\" Nature reviews Drug discovery 11(2): 125\u2013140.","journal-title":"Nature reviews Drug discovery"},{"issue":"4","key":"6_CR115","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1640","volume":"12","author":"A Kotowska-Zimmer","year":"2021","unstructured":"Kotowska-Zimmer, A., M. Pewinska and M. Olejniczak (2021). \"Artificial miRNAs as therapeutic tools: Challenges and opportunities.\" Wiley Interdisciplinary Reviews: RNA 12(4): e1640.","journal-title":"Wiley Interdisciplinary Reviews: RNA"},{"issue":"3","key":"6_CR116","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3324\/haematol.2013.093500","volume":"99","author":"L Kubiczkova","year":"2014","unstructured":"Kubiczkova, L., F. Kryukov, O. Slaby, E. Dementyeva, J. Jarkovsky, J. Nekvindova, L. Radova, H. Greslikova, P. Kuglik and E. Vetesnikova (2014). \"Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.\" Haematologica 99(3): 511.","journal-title":"Haematologica"},{"issue":"2","key":"6_CR117","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1053\/j.seminhematol.2018.04.008","volume":"55","author":"D Lavelle","year":"2018","unstructured":"Lavelle, D., J. D. Engel and Y. Saunthararajah (2018). \"Fetal Hemoglobin Induction by Epigenetic Drugs.\" Semin Hematol 55(2): 60\u201367.","journal-title":"Semin Hematol"},{"issue":"2","key":"6_CR118","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ymthe.2024.01.015","volume":"32","author":"A Leonard","year":"2024","unstructured":"Leonard, A. and J. F. Tisdale (2024). \"A new frontier: FDA approvals for gene therapy in sickle cell disease.\" Mol Ther 32(2): 264\u2013267.","journal-title":"Mol Ther"},{"issue":"4","key":"6_CR119","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12632","volume":"52","author":"C Li","year":"2019","unstructured":"Li, C., F. Tan, Q. Pei, Z. Zhou, Y. Zhou, L. Zhang, D. Wang and H. Pei (2019). \"Non-coding RNA MFI2-AS1 promotes colorectal cancer cell proliferation, migration and invasion through miR-574-5p\/MYCBP axis.\" Cell proliferation 52(4): e12632.","journal-title":"Cell proliferation"},{"issue":"4","key":"6_CR120","first-page":"772","volume":"7","author":"J-Q Li","year":"2015","unstructured":"Li, J.-Q., S.-Y. Hu, Z.-Y. Wang, J. Lin, S. Jian, Y.-C. Dong, X.-F. Wu, D. Lan and L.-J. Cao (2015b). \"MicroRNA-125-5p targeted CXCL13: a potential biomarker associated with immune thrombocytopenia.\" American Journal of Translational Research 7(4): 772.","journal-title":"American Journal of Translational Research"},{"key":"6_CR121","doi-asserted-by":"publisher","first-page":"10623","DOI":"10.2147\/IJN.S480095","volume":"19","author":"T Li","year":"2024","unstructured":"Li, T., Y. Chen and S. Li (2024). \"The Advances in the Development of Epigenetic Modifications Therapeutic Drugs Delivery Systems.\" Int J Nanomedicine 19: 10623\u201310637.","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"6_CR122","first-page":"499","volume":"121","author":"Y Li","year":"2013","unstructured":"Li, Y., L. Gao, X. Luo, L. Wang, X. Gao, W. Wang, J. Sun, L. Dou, J. Li and C. Xu (2013). \"Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t (8; 21) acute myeloid leukemia by activating the PTEN\/PI3K signal pathway.\" Blood, The Journal of the American Society of Hematology 121(3): 499\u2013509.","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"3","key":"6_CR123","first-page":"150","volume":"5","author":"Y Li","year":"2023","unstructured":"Li, Y., H. Zhang, B. Hu, P. Wang, W. Wang and J. Liu (2023). \"Post-transcriptional regulation of erythropoiesis.\" Blood Science 5(3): 150\u2013159.","journal-title":"Blood Science"},{"issue":"17","key":"6_CR124","first-page":"2005","volume":"126","author":"Z Li","year":"2015","unstructured":"Li, Z., P. Chen, R. Su, Y. Li, C. Hu, Y. Wang, S. Arnovitz, M. He, S. Gurbuxani and Z. Zuo (2015a). \"Overexpression and knockout of miR-126 both promote leukemogenesis.\" Blood, The Journal of the American Society of Hematology 126(17): 2005\u20132015.","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"8","key":"6_CR125","doi-asserted-by":"publisher","first-page":"8928","DOI":"10.3390\/molecules17088928","volume":"17","author":"Y-R Liao","year":"2012","unstructured":"Liao, Y.-R., Y.-L. Leu, Y.-Y. Chan, P.-C. Kuo and T.-S. Wu (2012). \"Anti-Platelet Aggregation and Vasorelaxing Effects of the Constituents of the Rhizomes of Zingiber officinale.\" Molecules 17(8): 8928\u20138937.","journal-title":"Molecules"},{"key":"6_CR126","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s12094-014-1237-z","volume":"17","author":"X Lin","year":"2015","unstructured":"Lin, X., Z. Wang, R. Zhang and W. Feng (2015). \"High serum microRNA-335 level predicts aggressive tumor progression and unfavorable prognosis in pediatric acute myeloid leukemia.\" Clinical and Translational Oncology 17: 358\u2013364.","journal-title":"Clinical and Translational Oncology"},{"issue":"11","key":"6_CR127","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrd4140","volume":"12","author":"H Ling","year":"2013","unstructured":"Ling, H., M. Fabbri and G. A. Calin (2013). \"MicroRNAs and other non-coding RNAs as targets for anticancer drug development.\" Nature reviews Drug discovery 12(11): 847\u2013865.","journal-title":"Nature reviews Drug discovery"},{"issue":"10","key":"6_CR128","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1182\/bloodadvances.2022008757","volume":"8","author":"L Ling","year":"2024","unstructured":"Ling, L., F. Wang, Y. Li, S. He, F. Wu, L. Yang, L. Xu, T. Wang, S. Zhou and F. Yang (2024). \"Depletion of miR-144\/451 alleviates anemia in \u03b2-thalassemic mice.\" Blood Advances 8(10): 2565\u20132570.","journal-title":"Blood Advances"},{"issue":"8","key":"6_CR129","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1080\/14737140.2022.2093720","volume":"22","author":"S Liu","year":"2022","unstructured":"Liu, S., Z. Sun, M. Zhu, M. Liu, M. Wei, X. Pan and S. Huang (2022a). \"Prognostic value and potential mechanism of long non-coding RNA Lnc-SMIM20-1 in acute myeloid leukemia.\" Expert Review of Anticancer Therapy 22(8): 875\u2013885.","journal-title":"Expert Review of Anticancer Therapy"},{"key":"6_CR130","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2020.108963","volume":"317","author":"XL Liu","year":"2020","unstructured":"Liu, X. L., H. Q. Liu, J. Li, C. Y. Mao, J. T. He and X. Zhao (2020). \"Role of epigenetic in leukemia: From mechanism to therapy.\" Chem Biol Interact 317: 108963.","journal-title":"Chem Biol Interact"},{"issue":"6","key":"6_CR131","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3390\/ijms9060978","volume":"9","author":"Z Liu","year":"2008","unstructured":"Liu, Z., A. Sall and D. Yang (2008). \"MicroRNA: an emerging therapeutic target and intervention tool.\" International journal of molecular sciences 9(6): 978\u2013999.","journal-title":"International journal of molecular sciences"},{"key":"6_CR132","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bbrc.2022.06.054","volume":"620","author":"Z Liu","year":"2022","unstructured":"Liu, Z., L. Zhong, W. Dan, X. Chu, C. Liu, X. Luo, Z. Zhang, Y. Lu, P. Wan and X. Wang (2022b). \"miRNA-222-3p enhances the proliferation and suppresses the apoptosis of acute myeloid leukemia cells by targeting Axin2 and modulating the Wnt\/\u03b2-catenin pathway.\" Biochemical and Biophysical Research Communications 620: 83\u201391.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"7","key":"6_CR133","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/biom10071044","volume":"10","author":"V Lodde","year":"2020","unstructured":"Lodde, V., G. Murgia, E. R. Simula, M. Steri, M. Floris and M. L. Idda (2020). \"Long noncoding RNAs and circular RNAs in autoimmune diseases.\" Biomolecules & therapeutics 10(7): 1044.","journal-title":"Biomolecules & therapeutics"},{"issue":"1","key":"6_CR134","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13148-023-01531-8","volume":"15","author":"G Lu","year":"2023","unstructured":"Lu, G., S. Jin, S. Lin, Y. Gong, L. Zhang, J. Yang, W. Mou and J. Du (2023). \"Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL).\" Clin Epigenetics 15(1): 124.","journal-title":"Clin Epigenetics"},{"issue":"1","key":"6_CR135","doi-asserted-by":"publisher","first-page":"36687","DOI":"10.1038\/srep36687","volume":"6","author":"M Luo","year":"2016","unstructured":"Luo, M., R. Li, M. Ren, N. Chen, X. Deng, X. Tan, Y. Li, M. Zeng, Y. Yang and Q. Wan (2016). \"Hyperglycaemia-induced reciprocal changes in miR-30c and PAI-1 expression in platelets.\" Scientific reports 6(1): 36687.","journal-title":"Scientific reports"},{"issue":"1","key":"6_CR136","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/s41420-020-00359-y","volume":"6","author":"X Ma","year":"2020","unstructured":"Ma, X., W. Zhang, M. Zhao, S. Li, W. Jin and K. Wang (2020). \"Oncogenic role of lncRNA CRNDE in acute promyelocytic leukemia and NPM1-mutant acute myeloid leukemia.\" Cell Death Discovery 6(1): 121.","journal-title":"Cell Death Discovery"},{"issue":"17","key":"6_CR137","first-page":"2429","volume":"129","author":"S Manier","year":"2017","unstructured":"Manier, S., C.-J. Liu, H. Avet-Loiseau, J. Park, J. Shi, F. Campigotto, K. Z. Salem, D. Huynh, S. V. Glavey and B. Rivotto (2017). \"Prognostic role of circulating exosomal miRNAs in multiple myeloma.\" Blood, The Journal of the American Society of Hematology 129(17): 2429\u20132436.","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"17","key":"6_CR138","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1200\/JCO.2012.45.6228","volume":"31","author":"G Marcucci","year":"2013","unstructured":"Marcucci, G., K. S. Maharry, K. H. Metzeler, S. Volinia, Y.-Z. Wu, K. Mr\u00f3zek, D. Nicolet, J. Kohlschmidt, S. P. Whitman and J. H. Mendler (2013). \"Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients.\" Journal of clinical oncology 31(17): 2086\u20132093.","journal-title":"Journal of clinical oncology"},{"issue":"10","key":"6_CR139","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0141119","volume":"10","author":"W Marx","year":"2015","unstructured":"Marx, W., D. McKavanagh, A. L. McCarthy, R. Bird, K. Ried, A. Chan and L. Isenring (2015). \"The Effect of Ginger (Zingiber officinale) on Platelet Aggregation: A Systematic Literature Review.\" PLoS One 10(10): e0141119.","journal-title":"PLoS One"},{"key":"6_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120965","volume":"309","author":"NA Mehana","year":"2022","unstructured":"Mehana, N. A., H. R. Ghaiad, M. Hassan, Y. A. Elsabagh, S. Labib and M. A. Abd-Elmawla (2022). \"LncRNA MEG3 regulates the interplay between Th17 and Treg cells in Beh\u00e7et's disease and systemic lupus erythematosus.\" Life Sciences 309: 120965.","journal-title":"Life Sciences"},{"key":"6_CR141","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1016\/j.biopha.2018.07.133","volume":"106","author":"F Memari","year":"2018","unstructured":"Memari, F., Z. Joneidi, B. Taheri, S. F. Aval, A. Roointan and N. Zarghami (2018). \"Epigenetics and Epi-miRNAs: Potential markers\/therapeutics in leukemia.\" Biomed Pharmacother 106: 1668\u20131677.","journal-title":"Biomed Pharmacother"},{"issue":"51\u201352","key":"6_CR142","first-page":"887","volume":"119","author":"W Miesbach","year":"2022","unstructured":"Miesbach, W., R. Klamroth, J. Oldenburg and A. Tiede (2022). \"Gene Therapy for Hemophilia-Opportunities and Risks.\" Dtsch Arztebl Int 119(51\u201352): 887\u2013894.","journal-title":"Dtsch Arztebl Int"},{"issue":"11","key":"6_CR143","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1111\/j.1753-4887.1996.tb03823.x","volume":"54","author":"JA Milner","year":"1996","unstructured":"Milner, J. A. (1996). \"Garlic: its anticarcinogenic and antiumorigenic properties.\" Nutrition reviews 54(11): S82.","journal-title":"Nutrition reviews"},{"key":"6_CR144","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12986-019-0421-0","volume":"17","author":"P Mirmiran","year":"2020","unstructured":"Mirmiran, P., Z. Houshialsadat, Z. Gaeini, Z. Bahadoran and F. Azizi (2020). \"Functional properties of beetroot (Beta vulgaris) in management of cardio-metabolic diseases.\" Nutrition & metabolism 17: 1\u201315.","journal-title":"Nutrition & metabolism"},{"key":"6_CR145","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.omtn.2019.02.023","volume":"16","author":"G Misso","year":"2019","unstructured":"Misso, G., M. R. Zarone, A. Lombardi, A. Grimaldi, A. M. Cossu, C. Ferri, M. Russo, D. C. Vuoso, A. Luce and H. Kawasaki (2019). \"miR-125b upregulates miR-34a and sequentially activates stress adaption and cell death mechanisms in multiple myeloma.\" Molecular Therapy-Nucleic Acids 16: 391\u2013406.","journal-title":"Molecular Therapy-Nucleic Acids"},{"key":"6_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-0952-z","volume":"18","author":"N Mittal","year":"2019","unstructured":"Mittal, N., L. Li, Y. Sheng, C. Hu, F. Li, T. Zhu, X. Qiao and Z. Qian (2019). \"A critical role of epigenetic inactivation of miR-9 in EVI1 high pediatric AML.\" Molecular cancer 18: 1\u20136.","journal-title":"Molecular cancer"},{"issue":"1","key":"6_CR147","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s10038-020-00845-2","volume":"66","author":"Y Momozawa","year":"2021","unstructured":"Momozawa, Y. and K. Mizukami (2021). \"Unique roles of rare variants in the genetics of complex diseases in humans.\" Journal of human genetics 66(1): 11\u201323.","journal-title":"Journal of human genetics"},{"key":"6_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bcmd.2017.11.003","volume":"69","author":"TA Morrison","year":"2018","unstructured":"Morrison, T. A., I. Wilcox, H.-Y. Luo, J. J. Farrell, R. Kurita, Y. Nakamura, G. J. Murphy, S. Cui, M. H. Steinberg and D. H. Chui (2018). \"A long noncoding RNA from the HBS1L-MYB intergenic region on chr6q23 regulates human fetal hemoglobin expression.\" Blood Cells, Molecules, and Diseases 69: 1\u20139.","journal-title":"Blood Cells, Molecules, and Diseases"},{"issue":"6","key":"6_CR149","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1080\/10428194.2016.1247956","volume":"58","author":"AJ Moskowitz","year":"2017","unstructured":"Moskowitz, A. J. and S. M. Horwitz (2017). \"Targeting histone deacetylases in T-cell lymphoma.\" Leuk Lymphoma 58(6): 1306\u20131319.","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"6_CR150","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.bbrc.2015.11.054","volume":"468","author":"AM Mostafa","year":"2015","unstructured":"Mostafa, A. M., N. M. Hamdy, H. O. El-Mesallamy and S. Z. Abdel-Rahman (2015). \"Glucagon-like peptide 1 (GLP-1)-based therapy upregulates LXR-ABCA1\/ABCG1 cascade in adipocytes.\" Biochemical and Biophysical Research Communications 468(4): 900\u2013905.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"6_CR151","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41435-023-00200-3","volume":"24","author":"M Naguib","year":"2023","unstructured":"Naguib, M., S. El Sawy, L. Rashed, M. AlHelf and M. Abdelgwad (2023). \"Long non-coding RNA maternally expressed gene 3, miR-125a-5p, CXCL13, and NF-kB in patients with immune thrombocytopenia.\" Genes & Immunity 24(2): 108\u2013115.","journal-title":"Genes & Immunity"},{"key":"6_CR152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-015-0162-0","volume":"8","author":"S Naidu","year":"2015","unstructured":"Naidu, S., P. Magee and M. Garofalo (2015). \"MiRNA-based therapeutic intervention of cancer.\" Journal of hematology & oncology 8: 1\u20138.","journal-title":"Journal of hematology & oncology"},{"issue":"5","key":"6_CR153","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036209","volume":"7","author":"S Nakamura","year":"2012","unstructured":"Nakamura, S., M. Oshima, J. Yuan, A. Saraya, S. Miyagi, T. Konuma, S. Yamazaki, M. Osawa, H. Nakauchi, H. Koseki and A. Iwama (2012). \"Bmi1 confers resistance to oxidative stress on hematopoietic stem cells.\" PLoS One 7(5): e36209.","journal-title":"PLoS One"},{"issue":"3","key":"6_CR154","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41576-023-00662-1","volume":"25","author":"K Nemeth","year":"2024","unstructured":"Nemeth, K., R. Bayraktar, M. Ferracin and G. A. Calin (2024). \"Non-coding RNAs in disease: from mechanisms to therapeutics.\" Nature Reviews Genetics 25(3): 211\u2013232.","journal-title":"Nature Reviews Genetics"},{"key":"6_CR155","unstructured":"Nurk, S., S. Koren, A. Rhie, M. Rautiainen, A. V. Bzikadze, A. Mikheenko, M. R. Vollger, N. Altemose, L. Uralsky and A. Gershman \"The complete sequence of a human genome., 2022, Science 376(6588): 44\u201353."},{"issue":"4\u20135","key":"6_CR156","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.thromres.2003.09.009","volume":"111","author":"E Nurtjahja-Tjendraputra","year":"2003","unstructured":"Nurtjahja-Tjendraputra, E., A. J. Ammit, B. D. Roufogalis, V. H. Tran and C. C. Duke (2003). \"Effective anti-platelet and COX-1 enzyme inhibitors from pungent constituents of ginger.\" Thromb Res 111(4\u20135): 259\u2013265.","journal-title":"Thromb Res"},{"key":"6_CR157","doi-asserted-by":"publisher","first-page":"1426454","DOI":"10.3389\/fmmed.2024.1426454","volume":"4","author":"AH Nwabo Kamdje","year":"2024","unstructured":"Nwabo Kamdje, A. H., H. P. Dongmo Fogang and P. N. Mimche (2024). \"Role of epigenetic in cancer biology, in hematologic malignancies and in anticancer therapy.\" Front Mol Med 4: 1426454.","journal-title":"Front Mol Med"},{"issue":"7","key":"6_CR158","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1089\/jmf.2012.0254","volume":"16","author":"SN Omoregie","year":"2013","unstructured":"Omoregie, S. N., F. O. Omoruyi, V. F. Wright, L. Jones and P. V. Zimba (2013). \"Antiproliferative activities of lesser galangal (Alpinia officinarum Hance Jam1), turmeric (Curcuma longa L.), and ginger (Zingiber officinale Rosc.) against acute monocytic leukemia.\" Journal of medicinal food 16(7): 647\u2013655.","journal-title":"Journal of medicinal food"},{"issue":"5","key":"6_CR159","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.cell.2020.09.047","volume":"183","author":"AF Palazzo","year":"2020","unstructured":"Palazzo, A. F. and E. V. Koonin (2020). \"Functional long non-coding RNAs evolve from junk transcripts.\" Cell 183(5): 1151\u20131161.","journal-title":"Cell"},{"key":"6_CR160","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcdb.2022.02.010","volume":"131","author":"P Paloviita","year":"2022","unstructured":"Paloviita, P. and S. Vuoristo (2022). \"The non-coding genome in early human development \u2013 Recent advancements.\" Seminars in Cell & Developmental Biology 131: 4\u201313.","journal-title":"Seminars in Cell & Developmental Biology"},{"issue":"11","key":"6_CR161","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.1016\/j.ymthe.2024.09.036","volume":"32","author":"Q Pan","year":"2024","unstructured":"Pan, Q., X. Xin, S. Mahto, Y. Dong, V. Kumar, R. K. Hyde, N. Gupta, V. R. Bhatt and R. I. Mahato (2024). \"Anti-CLL1 liposome loaded with miR-497-5p and venetoclax as a novel therapeutic strategy in acute myeloid leukemia.\" Molecular Therapy 32(11): 4058\u20134074.","journal-title":"Molecular Therapy"},{"issue":"2","key":"6_CR162","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12913","volume":"54","author":"B Peng","year":"2021","unstructured":"Peng, B., P. Y. Theng and M. T. Le (2021). \"Essential functions of miR-125b in cancer.\" Cell proliferation 54(2): e12913.","journal-title":"Cell proliferation"},{"issue":"3","key":"6_CR163","doi-asserted-by":"publisher","first-page":"339","DOI":"10.37349\/eds.2024.00050","volume":"2","author":"MG Pillai","year":"2024","unstructured":"Pillai, M. G. and H. Antony (2024). \"Harnessing the immunomodulatory potential of natural products in precision medicine\u2014a comprehensive review.\" Exploration of Drug Science 2(3): 339\u2013360.","journal-title":"Exploration of Drug Science"},{"issue":"2","key":"6_CR164","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/ncrna7020029","volume":"7","author":"G Pisignano","year":"2021","unstructured":"Pisignano, G. and M. Ladomery (2021). \"Post-transcriptional regulation through long non-coding rnas (lncrnas).\" Non-coding RNA 7(2): 29.","journal-title":"Non-coding RNA"},{"issue":"10423","key":"6_CR165","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0140-6736(23)01724-5","volume":"403","author":"U Platzbecker","year":"2024","unstructured":"Platzbecker, U., V. Santini, P. Fenaux, M. A. Sekeres, M. R. Savona, Y. F. Madanat, M. Diez-Campelo, D. Valcarcel, T. Illmer, A. Jonasova, P. Belohlavkova, L. J. Sherman, T. Berry, S. Dougherty, S. Shah, Q. Xia, L. Sun, Y. Wan, F. Huang, A. Ikin, S. Navada, F. Feller, R. S. Komrokji and A. M. Zeidan (2024). \"Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial.\" Lancet 403(10423): 249\u2013260.","journal-title":"Lancet"},{"issue":"14","key":"6_CR166","first-page":"3314","volume":"113","author":"R Popovic","year":"2009","unstructured":"Popovic, R., L. E. Riesbeck, C. S. Velu, A. Chaubey, J. Zhang, N. J. Achille, F. E. Erfurth, K. Eaton, J. Lu and H. L. Grimes (2009). \"Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization.\" Blood, The Journal of the American Society of Hematology 113(14): 3314\u20133322.","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"1","key":"6_CR167","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13072-024-00554-6","volume":"17","author":"R Prabhakaran","year":"2024","unstructured":"Prabhakaran, R., R. Thamarai, S. Sivasamy, S. Dhandayuthapani, J. Batra, C. Kamaraj, K. Karthik, M. A. Shah and S. Mallik (2024). \"Epigenetic frontiers: miRNAs, long non-coding RNAs and nanomaterials are pioneering to cancer therapy.\" Epigenetics & Chromatin 17(1): 31.","journal-title":"Epigenetics & Chromatin"},{"issue":"6","key":"6_CR168","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.cell.2012.02.045","volume":"148","author":"E Pujadas","year":"2012","unstructured":"Pujadas, E. and A. P. Feinberg (2012). \"Regulated noise in the epigenetic landscape of development and disease.\" Cell 148(6): 1123\u20131131.","journal-title":"Cell"},{"key":"6_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110812","volume":"132","author":"W Qi","year":"2020","unstructured":"Qi, W., X. Yan, X. Xu, B. Song, L. Sun, D. Zhao and L. Sun (2020). \"The effects of cytarabine combined with ginsenoside compound K synergistically induce DNA damage in acute myeloid leukemia cells.\" Biomedicine & Pharmacotherapy 132: 110812.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"1","key":"6_CR170","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1159\/000486811","volume":"45","author":"C Qian","year":"2018","unstructured":"Qian, C., W. Yan, T. Li, Q. Cui, P. Liu, M. Gu, J. Guo, W. Zhang, C. Ren and T. Wu (2018). \"Differential expression of MiR-106b-5p and MiR-200c-3p in newly diagnosed versus chronic primary immune thrombocytopenia patients based on systematic analysis.\" Cellular Physiology and Biochemistry 45(1): 301\u2013318.","journal-title":"Cellular Physiology and Biochemistry"},{"key":"6_CR171","doi-asserted-by":"crossref","unstructured":"Qiang, P., Q. Pan, C. Fang, C. Fozza, K. Song, Y. Dai, W. Chang, W. Chen, W. Yao and W. Zhu (2020). \"MicroRNA-181a-3p as a diagnostic and prognostic biomarker for acute myeloid leukemia.\" Mediterranean journal of hematology and infectious diseases 12(1).","DOI":"10.4084\/mjhid.2020.012"},{"key":"6_CR172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-014-0219-x","volume":"31","author":"X Qu","year":"2014","unstructured":"Qu, X., M. Zhao, S. Wu, W. Yu, J. Xu, J. Xu, J. Li and L. Chen (2014). \"Circulating microRNA 483-5p as a novel biomarker for diagnosis survival prediction in multiple myeloma.\" Medical oncology 31: 1\u20138.","journal-title":"Medical oncology"},{"issue":"4","key":"6_CR173","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3233\/CBM-160603","volume":"16","author":"SM Radwan","year":"2016","unstructured":"Radwan, S. M., N. M. Hamdy, H. M. Hegab and H. O. El-Mesallamy (2016). \"Beclin-1 and hypoxia-inducible factor-1\u03b1 genes expression: Potential biomarkers in acute leukemia patients.\" Cancer Biomarkers 16(4): 619\u2013626.","journal-title":"Cancer Biomarkers"},{"issue":"11","key":"6_CR174","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1002\/mnfr.200700058","volume":"51","author":"K Rahman","year":"2007","unstructured":"Rahman, K. (2007). \"Effects of garlic on platelet biochemistry and physiology.\" Mol Nutr Food Res 51(11): 1335\u20131344.","journal-title":"Mol Nutr Food Res"},{"key":"6_CR175","doi-asserted-by":"crossref","unstructured":"Rametta, R., M. Meroni and P. Dongiovanni (2020). \"From Environment to Genome and Back: A Lesson from HFE Mutations.\" Int J Mol Sci 21(10).","DOI":"10.3390\/ijms21103505"},{"issue":"1","key":"6_CR176","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.21608\/ejhm.2022.227002","volume":"87","author":"N Rashad","year":"2022","unstructured":"Rashad, N., U. A. Khalil, A. M. El-Helaly, M. H. Soliman and M. M. Sherif (2022). \"LncRNA MEG3 in Promoting Antiphospholipid Syndrome Nephropathy in Patients with Systemic Lupus Erythematosus.\" The Egyptian Journal of Hospital Medicine 87(1): 1591\u20131598.","journal-title":"The Egyptian Journal of Hospital Medicine"},{"key":"6_CR177","doi-asserted-by":"crossref","unstructured":"Rasool, M., A. Malik, M. I. Naseer, A. Manan, S. Ansari, I. Begum, M. H. Qazi, P. Pushparaj, A. M. Abuzenadah, M. H. Al-Qahtani, M. A. Kamal and S. Gan (2015). \"The role of epigenetics in personalized medicine: challenges and opportunities.\" BMC Med Genomics 8 (Suppl 1): S5.","DOI":"10.1186\/1755-8794-8-S1-S5"},{"issue":"40","key":"6_CR178","doi-asserted-by":"publisher","first-page":"10731","DOI":"10.1073\/pnas.1708264114","volume":"114","author":"LZ Rassenti","year":"2017","unstructured":"Rassenti, L. Z., V. Balatti, E. M. Ghia, A. Palamarchuk, L. Tomasello, P. Fadda, Y. Pekarsky, G. F. Widhopf, T. J. Kipps and C. M. Croce (2017). \"MicroRNA dysregulation to identify therapeutic target combinations for chronic lymphocytic leukemia.\" Proceedings of the National Academy of Sciences 114(40): 10731\u201310736.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"7","key":"6_CR179","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41419-020-02738-w","volume":"11","author":"J Rea","year":"2020","unstructured":"Rea, J., V. Menci, P. Tollis, T. Santini, A. Armaos, M. G. Garone, F. Iberite, A. Cipriano, G. G. Tartaglia and A. Rosa (2020). \"HOTAIRM1 regulates neuronal differentiation by modulating NEUROGENIN 2 and the downstream neurogenic cascade.\" Cell death & disease 11(7): 527.","journal-title":"Cell death & disease"},{"issue":"10","key":"6_CR180","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","volume":"19","author":"TC Roberts","year":"2020","unstructured":"Roberts, T. C., R. Langer and M. J. Wood (2020). \"Advances in oligonucleotide drug delivery.\" Nature reviews Drug discovery 19(10): 673\u2013694.","journal-title":"Nature reviews Drug discovery"},{"issue":"5","key":"6_CR181","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1365-2141.2008.07237.x","volume":"142","author":"A Roehle","year":"2008","unstructured":"Roehle, A., K. P. Hoefig, D. Repsilber, C. Thorns, M. Ziepert, K. O. Wesche, M. Thiere, M. Loeffler, W. Klapper and M. Pfreundschuh (2008). \"MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas.\" British journal of haematology 142(5): 732\u2013744.","journal-title":"British journal of haematology"},{"key":"6_CR182","doi-asserted-by":"publisher","first-page":"1281200","DOI":"10.3389\/fcell.2023.1281200","volume":"11","author":"B Roy","year":"2023","unstructured":"Roy, B., S. Dutta and C. Mukherjee (2023). \"Role of non-coding RNAs in development and metastasis of solid tumours.\" Frontiers in Cell and Developmental Biology 11: 1281200.","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"3","key":"6_CR183","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3390\/genes13030425","volume":"13","author":"B Roy","year":"2022","unstructured":"Roy, B., E. Lee, T. Li and M. Rampersaud (2022). \"Role of miRNAs in neurodegeneration: From disease cause to tools of biomarker discovery and therapeutics.\" Genes 13(3): 425.","journal-title":"Genes"},{"issue":"10","key":"6_CR184","doi-asserted-by":"publisher","first-page":"EVIDoa2200034","DOI":"10.1056\/EVIDoa2200034","volume":"1","author":"K Sasaki","year":"2022","unstructured":"Sasaki, K., E. Jabbour, G. Montalban-Bravo, F. Darbaniyan, K. A. Do, C. Class, N. J. Short, R. Kanagal-Shamana, T. Kadia, G. Borthakur, N. Pemmaraju, J. Cortes, F. Ravandi, Y. Alvarado, K. Chien, R. Komrokji, M. A. Sekeres, D. P. Steensma, A. DeZern, G. Roboz, K. Soltysiak, H. Yang, H. M. Kantarjian and G. Garcia-Manero (2022). \"Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDS.\" NEJM Evid 1(10): EVIDoa2200034.","journal-title":"NEJM Evid"},{"issue":"4","key":"6_CR185","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s12185-012-1183-x","volume":"96","author":"G Sashida","year":"2012","unstructured":"Sashida, G. and A. Iwama (2012). \"Epigenetic regulation of hematopoiesis.\" Int J Hematol 96(4): 405\u2013412.","journal-title":"Int J Hematol"},{"key":"6_CR186","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2165\/01197065-200502030-00007","volume":"2","author":"J Savovi\u0107","year":"2005","unstructured":"Savovi\u0107, J., B. Wider and E. Ernst (2005). \"Effects of Ginkgo biloba on blood coagulation parameters: a systematic review of randomised clinical trials.\" Evidence-Based Integrative Medicine 2: 167\u2013176.","journal-title":"Evidence-Based Integrative Medicine"},{"issue":"4","key":"6_CR187","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt, A. M. and H. Y. Chang (2016). \"Long noncoding RNAs in cancer pathways.\" Cancer cell 29(4): 452\u2013463.","journal-title":"Cancer cell"},{"issue":"12","key":"6_CR188","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.exphem.2016.08.012","volume":"44","author":"E Schneider","year":"2016","unstructured":"Schneider, E., A. Staffas, L. R\u00f6hner, K. Krowiorz, M. Heuser, K. D\u00f6hner, L. Bullinger, H. D\u00f6hner, L. Fogelstrand and A. Rouhi (2016). \"MicroRNA-155 is upregulated in MLL-rearranged AML but its absence does not affect leukemia development.\" Experimental Hematology 44(12): 1166\u20131171.","journal-title":"Experimental Hematology"},{"issue":"1","key":"6_CR189","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/ncrna7010003","volume":"7","author":"M Sebastian-delaCruz","year":"2021","unstructured":"Sebastian-delaCruz, M., I. Gonzalez-Moro, A. Olazagoitia-Garmendia, A. Castellanos-Rubio and I. Santin (2021). \"The role of lncRNAs in gene expression regulation through mRNA stabilization.\" Non-coding RNA 7(1): 3.","journal-title":"Non-coding RNA"},{"issue":"8","key":"6_CR190","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41571-019-0190-8","volume":"16","author":"D Sermer","year":"2019","unstructured":"Sermer, D., L. Pasqualucci, H. G. Wendel, A. Melnick and A. Younes (2019). \"Emerging epigenetic-modulating therapies in lymphoma.\" Nat Rev Clin Oncol 16(8): 494\u2013507.","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"6_CR191","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.apjtb.2017.05.003","volume":"7","author":"VKL Shanbhag","year":"2017","unstructured":"Shanbhag, V. K. L. (2017). \"Curcumin in chronic lymphocytic leukemia \u2013 A review.\" Asian Pacific Journal of Tropical Biomedicine 7(6): 505\u2013512.","journal-title":"Asian Pacific Journal of Tropical Biomedicine"},{"issue":"5","key":"6_CR192","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1515\/cclm-2015-1108","volume":"55","author":"X Shen","year":"2017","unstructured":"Shen, X., Y. Ye, J. Qi, W. Shi, X. Wu, H. Ni, H. Cong and S. Ju (2017). \"Identification of a novel microRNA, miR-4449, as a potential blood based marker in multiple myeloma.\" Clinical Chemistry and Laboratory Medicine (CCLM) 55(5): 748\u2013754.","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"issue":"4","key":"6_CR193","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41576-020-0210-7","volume":"21","author":"RM Sherman","year":"2020","unstructured":"Sherman, R. M. and S. L. Salzberg (2020). \"Pan-genomics in the human genome era.\" Nature Reviews Genetics 21(4): 243\u2013254.","journal-title":"Nature Reviews Genetics"},{"key":"6_CR194","doi-asserted-by":"crossref","unstructured":"Shi, J., W. Ding and H. Lu (2020). \"Identification of long non-coding RNA SNHG family as promising prognostic biomarkers in acute Myeloid Leukemia.\" OncoTargets and therapy: 8441\u20138450.","DOI":"10.2147\/OTT.S265853"},{"issue":"5","key":"6_CR195","first-page":"923","volume":"68","author":"VS Sierpina","year":"2003","unstructured":"Sierpina, V. S., B. Wollschlaeger and M. Blumenthal (2003). \"Ginkgo biloba.\" American family physician 68(5): 923\u2013926.","journal-title":"American family physician"},{"key":"6_CR196","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.semcancer.2021.03.013","volume":"83","author":"M Singh","year":"2022","unstructured":"Singh, M., V. Kumar, N. Sehrawat, M. Yadav, M. Chaudhary, S. K. Upadhyay, S. Kumar, V. Sharma, S. Kumar, N. Dilbaghi and A. K. Sharma (2022). \"Current paradigms in epigenetic anticancer therapeutics and future challenges.\" Semin Cancer Biol 83: 422\u2013440.","journal-title":"Semin Cancer Biol"},{"key":"6_CR197","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00204-020-02916-x","volume":"95","author":"T Smutny","year":"2021","unstructured":"Smutny, T., L. Hyrsova, A. Braeuning, M. Ingelman-Sundberg and P. Pavek (2021). \"Transcriptional and post-transcriptional regulation of the pregnane X receptor: a rationale for interindividual variability in drug metabolism.\" Archives of Toxicology 95: 11\u201325.","journal-title":"Archives of Toxicology"},{"key":"6_CR198","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.exphem.2017.06.119","volume":"53","author":"P Sommerkamp","year":"2017","unstructured":"Sommerkamp, P., S. Renders, L. Ladel, K. Sch\u00f6nberger, P. Zeisberger, A. Przybylla, N. Cabezas-Wallscheid and A. Trumpp (2017). \"The role of the lncRNA Meg3 in the adult hematopoietic compartment.\" Experimental Hematology 53: S65.","journal-title":"Experimental Hematology"},{"issue":"1","key":"6_CR199","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.stem.2013.06.003","volume":"13","author":"SJ Song","year":"2013","unstructured":"Song, S. J., K. Ito, U. Ala, L. Kats, K. Webster, S. M. Sun, M. Jongen-Lavrencic, K. Manova-Todorova, J. Teruya-Feldstein and D. E. Avigan (2013). \"The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation.\" Cell stem cell 13(1): 87\u2013101.","journal-title":"Cell stem cell"},{"key":"6_CR200","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.767348","volume":"12","author":"DK Soni","year":"2021","unstructured":"Soni, D. K. and R. Biswas (2021). \"Role of non-coding RNAs in post-transcriptional regulation of lung diseases.\" Frontiers in Genetics 12: 767348.","journal-title":"Frontiers in Genetics"},{"issue":"2","key":"6_CR201","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello, L., C.-J. Guo, L.-L. Chen and M. Huarte (2021). \"Gene regulation by long non-coding RNAs and its biological functions.\" Nature reviews Molecular cell biology 22(2): 96\u2013118.","journal-title":"Nature reviews Molecular cell biology"},{"issue":"1","key":"6_CR202","doi-asserted-by":"publisher","first-page":"7193","DOI":"10.1038\/s41467-024-51296-8","volume":"15","author":"AR Sternberg","year":"2024","unstructured":"Sternberg, A. R., C. Martos-Rus, R. J. Davidson, X. Liu and L. A. George (2024). \"Pre-clinical evaluation of an enhanced-function factor VIII variant for durable hemophilia A gene therapy in male mice.\" Nat Commun 15(1): 7193.","journal-title":"Nat Commun"},{"issue":"7","key":"6_CR203","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1038\/s41375-021-01218-0","volume":"35","author":"J Stomper","year":"2021","unstructured":"Stomper, J., J. C. Rotondo, G. Greve and M. Lubbert (2021). \"Hypomethylating agents (HMA) for the treatment of acute myeloid leukemia and myelodysplastic syndromes: mechanisms of resistance and novel HMA-based therapies.\" Leukemia 35(7): 1873\u20131889.","journal-title":"Leukemia"},{"issue":"1","key":"6_CR204","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3892\/br.2020.1305","volume":"13","author":"H Sun","year":"2020","unstructured":"Sun, H., G. Peng, H. Wu, M. Liu, G. Mao, X. Ning, H. Yang and J. Deng (2020b). \"Long non-coding RNA MEG3 is involved in osteogenic differentiation and bone diseases.\" Biomedical reports 13(1): 15\u201321.","journal-title":"Biomedical reports"},{"issue":"3","key":"6_CR205","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/iub.2168","volume":"72","author":"S Sun","year":"2020","unstructured":"Sun, S., S. Chai, F. Zhang and L. Lu (2020a). \"Overexpressed microRNA-103a-3p inhibits acute lower-extremity deep venous thrombosis via inhibition of CXCL12.\" IUBMB life 72(3): 492\u2013504.","journal-title":"IUBMB life"},{"issue":"19","key":"6_CR206","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1161\/CIRCULATIONAHA.113.002731","volume":"128","author":"HR Superko","year":"2013","unstructured":"Superko, H. R., S. M. Superko, K. Nasir, A. Agatston and B. C. Garrett (2013). \"Omega-3 fatty acid blood levels: clinical significance and controversy.\" Circulation 128(19): 2154\u20132161.","journal-title":"Circulation"},{"issue":"1","key":"6_CR207","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.blre.2016.08.003","volume":"31","author":"LL Swystun","year":"2017","unstructured":"Swystun, L. L. and P. D. James (2017). \"Genetic diagnosis in hemophilia and von Willebrand disease.\" Blood Rev 31(1): 47\u201356.","journal-title":"Blood Rev"},{"issue":"1","key":"6_CR208","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41375-019-0542-5","volume":"34","author":"E Taiana","year":"2020","unstructured":"Taiana, E., V. Favasuli, D. Ronchetti, K. Todoerti, F. Pelizzoni, M. Manzoni, M. Barbieri, S. Fabris, I. Silvestris and M. E. Gallo Cantafio (2020). \"Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma.\" Leukemia 34(1): 234\u2013244.","journal-title":"Leukemia"},{"issue":"2","key":"6_CR209","first-page":"1","volume":"23","author":"Z Tan","year":"2021","unstructured":"Tan, Z., K. Zhu, Y. Yin and Z. Luo (2021). \"Long non-coding RNA ANRIL is a potential indicator of disease progression and poor prognosis in acute myeloid leukemia.\" Molecular Medicine Reports 23(2): 1\u20131.","journal-title":"Molecular Medicine Reports"},{"issue":"11","key":"6_CR210","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1042\/CS20120504","volume":"124","author":"J Tang","year":"2013","unstructured":"Tang, J., H. Yan and S. Zhuang (2013). \"Histone deacetylases as targets for treatment of multiple diseases.\" Clin Sci (Lond) 124(11): 651\u2013662.","journal-title":"Clin Sci (Lond)"},{"issue":"6","key":"6_CR211","doi-asserted-by":"publisher","first-page":"BSR20180598","DOI":"10.1042\/BSR20180598","volume":"38","author":"K-C Tang","year":"2018","unstructured":"Tang, K.-C., Z.-P. Yang, Q. Zeng, J. Wang, F. Guo and Y. Zhao (2018). \"Effect of miR-495 on lower extremity deep vein thrombosis through the TLR4 signaling pathway by regulation of IL1R1.\" Bioscience reports 38(6): BSR20180598.","journal-title":"Bioscience reports"},{"issue":"7","key":"6_CR212","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1515\/cclm-2018-0838","volume":"57","author":"A Terrinoni","year":"2019","unstructured":"Terrinoni, A., C. Calabrese, D. Basso, A. Aita, S. Caporali, M. Plebani and S. Bernardini (2019). \"The circulating miRNAs as diagnostic and prognostic markers.\" Clinical Chemistry and Laboratory Medicine (CCLM) 57(7): 932\u2013953.","journal-title":"Clinical Chemistry and Laboratory Medicine (CCLM)"},{"issue":"3","key":"6_CR213","first-page":"221","volume":"29","author":"D Trzybulska","year":"2018","unstructured":"Trzybulska, D., E. Vergadi and C. Tsatsanis (2018). \"miRNA and other non-coding RNAs as promising diagnostic markers.\" Ejifcc 29(3): 221.","journal-title":"Ejifcc"},{"issue":"3","key":"6_CR214","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1177\/146642409011000306","volume":"110","author":"M Turner","year":"1990","unstructured":"Turner, M. (1990). \"Garlic and circulatory disorders.\" Journal of the Royal Society of Health 110(3): 90\u201393.","journal-title":"Journal of the Royal Society of Health"},{"key":"6_CR215","doi-asserted-by":"crossref","unstructured":"Venkatesan, V., S. Srinivasan, P. Babu and S. Thangavel (2020). \"Manipulation of Developmental Gamma-Globin Gene Expression: an Approach for Healing Hemoglobinopathies.\" Mol Cell Biol 41(1).","DOI":"10.1128\/MCB.00253-20"},{"issue":"22","key":"6_CR216","doi-asserted-by":"publisher","first-page":"5589","DOI":"10.1158\/0008-5472.CAN-21-1606","volume":"81","author":"N Wajapeyee","year":"2021","unstructured":"Wajapeyee, N. and R. Gupta (2021). \"Epigenetic Alterations and Mechanisms That Drive Resistance to Targeted Cancer Therapies.\" Cancer Res 81(22): 5589\u20135595.","journal-title":"Cancer Res"},{"issue":"20","key":"6_CR217","doi-asserted-by":"publisher","first-page":"5664","DOI":"10.1182\/blood-2011-07-368746","volume":"118","author":"AL Walker","year":"2011","unstructured":"Walker, A. L., S. Steward, T. A. Howard, N. Mortier, M. Smeltzer, Y. D. Wang and R. E. Ware (2011). \"Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia.\" Blood 118(20): 5664\u20135670.","journal-title":"Blood"},{"issue":"04","key":"6_CR218","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/CM9.0000000000000624","volume":"133","author":"F-Y Wang","year":"2020","unstructured":"Wang, F.-Y., Z.-Y. Gu and C.-J. Gao (2020). \"Emerging role of long non-coding RNAs in normal and malignant hematopoiesis.\" Chinese Medical Journal 133(04): 462\u2013473.","journal-title":"Chinese Medical Journal"},{"issue":"2","key":"6_CR219","first-page":"1473","volume":"18","author":"F Wang","year":"2018","unstructured":"Wang, F., X. Tian, J. Zhou, G. Wang, W. Yu, Z. Li, Z. Fan, W. Zhang and A. Liang (2018b). \"A three-lncRNA signature for prognosis prediction of acute myeloid leukemia in patients.\" Molecular medicine reports 18(2): 1473\u20131484.","journal-title":"Molecular medicine reports"},{"key":"6_CR220","doi-asserted-by":"crossref","unstructured":"Wang, S., J. Ma, H. Qiu, S. Liu, S. Zhang, H. Liu, P. Zhang, R.-l. Ge, G. Li and S. Cui (2023). \"Plasma exosomal microRNA expression profiles in patients with high-altitude polycythemia.\" Blood Cells, Molecules, and Diseases 98: 102707.","DOI":"10.1016\/j.bcmd.2022.102707"},{"issue":"3","key":"6_CR221","first-page":"1091","volume":"45","author":"XQ Wang","year":"2017","unstructured":"Wang, X. Q. and J. Dostie (2017). \"Reciprocal regulation of chromatin state and architecture by HOTAIRM1 contributes to temporal collinear HOXA gene activation.\" Nucleic acids research 45(3): 1091\u20131104.","journal-title":"Nucleic acids research"},{"issue":"21","key":"6_CR222","first-page":"7364","volume":"22","author":"Y Wang","year":"2018","unstructured":"Wang, Y., Y. Li, H. Song and G. Sun (2018a). \"Long non-coding RNA LINC00899 as a novel serum biomarker for diagnosis and prognosis prediction of acute myeloid leukemia.\" Eur Rev Med Pharmacol Sci 22(21): 7364\u20137370.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"6_CR223","unstructured":"Wang, Y., Q. Zhou and J.-J. Ma (2018c). \"High expression of lnc-CRNDE presents as a biomarker for acute myeloid leukemia and promotes the malignant progression in acute myeloid leukemia cell line U937.\" European Review for Medical & Pharmacological Sciences 22(3)."},{"issue":"11","key":"6_CR224","first-page":"1689","volume":"75","author":"B White","year":"2007","unstructured":"White, B. (2007). \"Ginger: an overview.\" American family physician 75(11): 1689\u20131691.","journal-title":"American family physician"},{"issue":"13","key":"6_CR225","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1182\/blood-2011-03-341446","volume":"118","author":"AJ Woo","year":"2011","unstructured":"Woo, A. J., J. Kim, J. Xu, H. Huang and A. B. Cantor (2011). \"Role of ZBP-89 in human globin gene regulation and erythroid differentiation.\" Blood 118(13): 3684\u20133693.","journal-title":"Blood"},{"issue":"1","key":"6_CR226","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1182\/blood-2015-07-604512","volume":"127","author":"BJ Wouters","year":"2016","unstructured":"Wouters, B. J. and R. Delwel (2016). \"Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia.\" Blood 127(1): 42\u201352.","journal-title":"Blood"},{"issue":"4","key":"6_CR227","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.3892\/ol.2015.3552","volume":"10","author":"S Wu","year":"2015","unstructured":"Wu, S., C. Zheng, S. Chen, X. Cai, Y. Shi, B. Lin and Y. Chen (2015). \"Overexpression of long non-coding RNA HOTAIR predicts a poor prognosis in patients with acute myeloid leukemia.\" Oncology letters 10(4): 2410\u20132414.","journal-title":"Oncology letters"},{"key":"6_CR228","doi-asserted-by":"crossref","unstructured":"Wu, X., J. Wang, D. Li and Z. Xu (2020). \"Expression and Diagnostic Value of lncRNA BLACAT1 in Peripheral Blood of Patients with Acute Myeloid Leukemia.\" Clinical Laboratory 86(4).","DOI":"10.7754\/Clin.Lab.2019.190802"},{"issue":"2","key":"6_CR229","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.yexcr.2018.06.026","volume":"370","author":"G Xiao","year":"2018","unstructured":"Xiao, G., Y. Li, Y. Wang, B. Zhao, Z. Zou, S. Hou, X. Jia, X. Liu, Y. Yao and J. Wan (2018). \"LncRNA PRAL is closely related to clinical prognosis of multiple myeloma and the bortezomib sensitivity.\" Experimental cell research 370(2): 254\u2013263.","journal-title":"Experimental cell research"},{"key":"6_CR230","doi-asserted-by":"publisher","first-page":"1033143","DOI":"10.3389\/fonc.2022.1033143","volume":"12","author":"Q Xiao","year":"2022","unstructured":"Xiao, Q., C. Lin, M. Peng, J. Ren, Y. Jing, L. Lei, Y. Tao, J. Huang, J. Yang and M. Sun (2022). \"Circulating plasma exosomal long non-coding RNAs LINC00265, LINC00467, UCA1, and SNHG1 as biomarkers for diagnosis and treatment monitoring of acute myeloid leukemia.\" Frontiers in Oncology 12: 1033143.","journal-title":"Frontiers in Oncology"},{"issue":"10","key":"6_CR231","doi-asserted-by":"publisher","first-page":"13194","DOI":"10.1096\/fj.202000941R","volume":"34","author":"L Xu","year":"2020","unstructured":"Xu, L., F. Wu, L. Yang, F. Wang, T. Zhang, X. Deng, X. Zhang, X. Yuan, Y. Yan and Y. Li (2020). \"miR-144\/451 inhibits c-Myc to promote erythroid differentiation.\" The FASEB Journal 34(10): 13194\u201313210.","journal-title":"The FASEB Journal"},{"key":"6_CR232","doi-asserted-by":"crossref","unstructured":"Xu, M., G.-N. Zhao, X. Lv, G. Liu, L. Y. Wang, D.-L. Hao, J. Wang, D.-P. Liu and C.-C. Liang (2014). \"CTCF controls HOXA cluster silencing and mediates PRC2-repressive higher-order chromatin structure in NT2\/D1 cells.\" Molecular and cellular biology.","DOI":"10.1128\/MCB.00567-14"},{"key":"6_CR233","doi-asserted-by":"publisher","first-page":"1292589","DOI":"10.3389\/frhem.2023.1292589","volume":"2","author":"L Xue","year":"2024","unstructured":"Xue, L., K. Mukherjee, K. A. Kelley and J. J. Bieker (2024). \"Generation, characterization, and use of EKLF (Klf1)\/CRE knock-in mice for cell-restricted analyses.\" Frontiers in Hematology 2: 1292589.","journal-title":"Frontiers in Hematology"},{"key":"6_CR234","doi-asserted-by":"crossref","unstructured":"Yang, L., J.-D. Zhou, T.-J. Zhang, J.-C. Ma, G.-F. Xiao, Q. Chen, Z.-Q. Deng, J. Lin, J. Qian and D.-M. Yao (2018). \"Overexpression of lncRNA PANDAR predicts adverse prognosis in acute myeloid leukemia.\" Cancer management and research: 4999\u20135007.","DOI":"10.2147\/CMAR.S180150"},{"issue":"8","key":"6_CR235","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/s41418-024-01305-6","volume":"31","author":"Q Yang","year":"2024","unstructured":"Yang, Q., L. Chen, H. Zhang, M. Li, L. Sun, X. Wu, H. Zhao, X. Qu, X. An and T. Wang (2024). \"DNMT1 regulates human erythropoiesis by modulating cell cycle and endoplasmic reticulum stress in a stage-specific manner.\" Cell Death Differ 31(8): 999\u20131012.","journal-title":"Cell Death Differ"},{"issue":"8","key":"6_CR236","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1016\/j.bbamcr.2015.04.014","volume":"1853","author":"XJ Yang","year":"2015","unstructured":"Yang, X. J. (2015). \"MOZ and MORF acetyltransferases: Molecular interaction, animal development and human disease.\" Biochim Biophys Acta 1853(8): 1818\u20131826.","journal-title":"Biochim Biophys Acta"},{"issue":"39","key":"6_CR237","doi-asserted-by":"publisher","first-page":"65211","DOI":"10.18632\/oncotarget.18059","volume":"8","author":"H Yao","year":"2017","unstructured":"Yao, H., P. Sun, M. Duan, L. Lin, Y. Pan, C. Wu, X. Fu, H. Wang, L. Guo and T. Jin (2017). \"microRNA-22 can regulate expression of the long non-coding RNA MEG3 in acute myeloid leukemia.\" Oncotarget 8(39): 65211.","journal-title":"Oncotarget"},{"issue":"47\u201355","key":"6_CR238","volume":"79","author":"Q Yin","year":"2019","unstructured":"Yin, Q., X. Shen, X. Cui and S. Ju (2019). \"Elevated serum lncRNA TUG1 levels are a potential diagnostic biomarker of multiple myeloma.\" Experimental hematology 79: 47\u201355. e42.","journal-title":"Experimental hematology"},{"issue":"9","key":"6_CR239","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23399","volume":"34","author":"H Yu","year":"2020","unstructured":"Yu, H., S. Peng, X. Chen, S. Han and J. Luo (2020). \"Long non-coding RNA NEAT1 serves as a novel biomarker for treatment response and survival profiles via microRNA-125a in multiple myeloma.\" Journal of clinical laboratory analysis 34(9): e23399.","journal-title":"Journal of clinical laboratory analysis"},{"issue":"1","key":"6_CR240","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1080\/16078454.2021.1974200","volume":"26","author":"L Yu","year":"2021","unstructured":"Yu, L., L. Zhang, Z. Jiang and B. Yu (2021). \"Decreasing lncRNA PVT1 causes Treg\/Th17 imbalance via NOTCH signaling in immune thrombocytopenia.\" Hematology 26(1): 734\u2013740.","journal-title":"Hematology"},{"issue":"1","key":"6_CR241","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12943-024-02084-x","volume":"23","author":"X Yu","year":"2024","unstructured":"Yu, X., Y. Zhang, F. Luo, Q. Zhou and L. Zhu (2024a). \"The role of microRNAs in the gastric cancer tumor microenvironment.\" Molecular Cancer 23(1): 170.","journal-title":"Molecular Cancer"},{"issue":"1","key":"6_CR242","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41420-024-01803-z","volume":"10","author":"X Yu","year":"2024","unstructured":"Yu, X., H. Zhao, R. Wang, Y. Chen, X. Ouyang, W. Li, Y. Sun and A. Peng (2024b). \"Cancer epigenetics: from laboratory studies and clinical trials to precision medicine.\" Cell Death Discovery 10(1): 28.","journal-title":"Cell Death Discovery"},{"key":"6_CR243","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2019.106261","volume":"88","author":"H Zeng","year":"2020","unstructured":"Zeng, H., H. Wu, M. Yan, L. Tang, X. Guo and X. Zhao (2020). \"Characterization of a 4 lncRNAs-based prognostic risk scoring system in adults with acute myeloid leukemia.\" Leukemia Research 88: 106261.","journal-title":"Leukemia Research"},{"issue":"20","key":"6_CR244","doi-asserted-by":"publisher","first-page":"20111","DOI":"10.18632\/aging.103614","volume":"12","author":"H Zhang","year":"2020","unstructured":"Zhang, H., J. Kang, L. Liu, L. Chen, S. Ren and Y. Tao (2020a). \"MicroRNA-143 sensitizes acute myeloid leukemia cells to cytarabine via targeting ATG7-and ATG2B-dependent autophagy.\" Aging (Albany NY) 12(20): 20111.","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"6_CR245","first-page":"1","volume":"21","author":"L Zhang","year":"2021","unstructured":"Zhang, L., L. Yu, Y. Liu, S. Wang, Z. Hou and J. Zhou (2021b). \"miR-21-5p promotes cell proliferation by targeting BCL11B in Thp-1 cells.\" Oncology letters 21(2): 1\u20131.","journal-title":"Oncology letters"},{"key":"6_CR246","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.copbio.2021.05.002","volume":"70","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q., W. Dou, C. N. T. Taning, G. Smagghe and J.-J. Wang (2021a). \"Regulatory roles of microRNAs in insect pests: prospective targets for insect pest control.\" Current Opinion in Biotechnology 70: 158\u2013166.","journal-title":"Current Opinion in Biotechnology"},{"key":"6_CR247","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.yjmcc.2020.05.011","volume":"144","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., X. Miao, Z. Zhang, R. Wei, S. Sun, G. Liang, H. Li, C. Chu, L. Zhao and X. Zhu (2020b). \"miR-374b-5p is increased in deep vein thrombosis and negatively targets IL-10.\" Journal of Molecular and Cellular Cardiology 144: 97\u2013108.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"2","key":"6_CR248","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1161\/ATVBAHA.119.313137","volume":"40","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y., Z. Zhang, R. Wei, X. Miao, S. Sun, G. Liang, C. Chu, L. Zhao, X. Zhu and Q. Guo (2020c). \"IL (Interleukin)-6 contributes to deep vein thrombosis and is negatively regulated by miR-338-5p.\" Arteriosclerosis, thrombosis, and vascular biology 40(2): 323\u2013334.","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"issue":"1","key":"6_CR249","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41392-023-01342-6","volume":"8","author":"A Zhao","year":"2023","unstructured":"Zhao, A., H. Zhou, J. Yang, M. Li and T. Niu (2023). \"Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies.\" Signal Transduction and Targeted Therapy 8(1): 71.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"3","key":"6_CR250","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41419-018-0305-7","volume":"9","author":"Q Zheng","year":"2018","unstructured":"Zheng, Q., Z. Lin, J. Xu, Y. Lu, Q. Meng, C. Wang, Y. Yang, X. Xin, X. Li and H. Pu (2018). \"Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting \u03b2-catenin by activating PKM2 and inactivating PTEN.\" Cell death & disease 9(3): 253.","journal-title":"Cell death & disease"},{"issue":"5","key":"6_CR251","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1159\/000447887","volume":"39","author":"Z Zheng","year":"2016","unstructured":"Zheng, Z., X. Li, Y. Zhu, W. Gu, X. Xie and J. Jiang (2016). \"Prognostic significance of MiRNA in patients with diffuse large B-Cell lymphoma: a meta-analysis.\" Cellular Physiology and Biochemistry 39(5): 1891\u20131904.","journal-title":"Cellular Physiology and Biochemistry"},{"issue":"4","key":"6_CR252","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3892\/or.2021.7962","volume":"45","author":"H Zhou","year":"2021","unstructured":"Zhou, H., Y. Ning, G. Zeng, C. Zhou and X. Ding (2021a). \"Curcumin promotes cell cycle arrest and apoptosis of acute myeloid leukemia cells by inactivating AKT.\" Oncol Rep 45(4): 11.","journal-title":"Oncol Rep"},{"key":"6_CR253","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113825","volume":"226","author":"M Zhou","year":"2021","unstructured":"Zhou, M., M. Yuan, M. Zhang, C. Lei, O. Aras, X. Zhang and F. An (2021b). \"Combining histone deacetylase inhibitors (HDACis) with other therapies for cancer therapy.\" Eur J Med Chem 226: 113825.","journal-title":"Eur J Med Chem"},{"issue":"26","key":"6_CR254","first-page":"2871","volume":"126","author":"Y Zhou","year":"2015","unstructured":"Zhou, Y., S. Abraham, P. Andre, L. C. Edelstein, C. A. Shaw, C. A. Dangelmaier, A. Y. Tsygankov, S. P. Kunapuli, P. F. Bray and S. E. McKenzie (2015). \"Anti\u2013miR-148a regulates platelet Fc\u03b3RIIA signaling and decreases thrombosis in vivo in mice.\" Blood, The Journal of the American Society of Hematology 126(26): 2871\u20132881.","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"5","key":"6_CR255","first-page":"2131","volume":"53","author":"B Zhu","year":"2018","unstructured":"Zhu, B., H. Chen, X. Zhang, Y. Pan, R. Jing, L. Shen, X. Wang, S. Ju, C. Jin and H. Cong (2018). \"Serum miR-30d as a novel biomarker for multiple myeloma and its antitumor role in U266 cells through the targeting of the MTDH\/PI3K\/Akt signaling pathway.\" International journal of oncology 53(5): 2131\u20132144.","journal-title":"International journal of oncology"},{"issue":"1","key":"6_CR256","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12859-023-05148-9","volume":"24","author":"Y Zhu","year":"2023","unstructured":"Zhu, Y., J. He, Z. Li and W. Yang (2023). \"Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia.\" BMC bioinformatics 24(1): 37.","journal-title":"BMC bioinformatics"}],"updated-by":[{"DOI":"10.1007\/978-3-032-08530-6_9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000}}],"container-title":["Subcellular Biochemistry","From (Epi)genetics-to-Precision (E2P)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-08530-6_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T05:02:34Z","timestamp":1772686954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-08530-6_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032085290","9783032085306"],"references-count":256,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-08530-6_6","relation":{},"ISSN":["0306-0225","2542-8810"],"issn-type":[{"value":"0306-0225","type":"print"},{"value":"2542-8810","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 January 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"6 March 2026","order":2,"name":"change_date","label":"Change Date","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"Correction","order":3,"name":"change_type","label":"Change Type","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"A correction has been published.","order":4,"name":"change_details","label":"Change Details","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}